subject: PUBCHEM.COMPOUND:44424639

object_name: Stage IV Uterine Sarcoma AJCC v7


subject: PUBCHEM.COMPOUND:44424639

subject_name: Vinorelbine

object_name: Stage IIIB Breast Carcinoma

tested_intervention: unsure


subject: PUBCHEM.COMPOUND:44424639

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:44424639

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:44424639

object_name: Malignant Paraganglioma


subject: UMLS:C4045705

object_name: High grade glioma

tested_intervention: yes


subject: UMLS:C4045705

object_name: malignant glioma


subject: CHEBI:73495

subject_name: Glu-Cys-Cys

object_name: short bowel syndrome


subject: PUBCHEM.COMPOUND:13559282

subject_name: Ulipristal acetate

object_name: Dysmenorrhea, CTCAE


subject: PUBCHEM.COMPOUND:13559282

object_name: Dysmenorrhea


subject: PUBCHEM.COMPOUND:13559282

object_name: uterine bleeding heavy


subject: CHEBI:71025

subject_name: ulipristal


subject: CHEBI:71025


subject: CHEBI:71025


subject: CHEBI:29746

subject_name: glycocholate

object_name: Bile Acid Synthesis Defect


subject: CHEBI:170867


subject: PUBCHEM.COMPOUND:77335690

subject_name: Velpatasvir

object_name: Cirrhosis


subject: PUBCHEM.COMPOUND:77335690

object_name: liver cirrhosis


subject: PUBCHEM.COMPOUND:122197547

subject_name: VOXILAPREVIR


subject: PUBCHEM.COMPOUND:122197547


subject: CHEBI:201431

subject_name: Cyclosporin H

object_name: Hypoplastic anemia


subject: CHEBI:4031

subject_name: Cyclosporine


subject: UMLS:C0004149

subject_name: ATGAM


subject: UMLS:C1871272

subject_name: TachoSil

object_name: Complication of transplanted liver


subject: CHEBI:16947

object_name: Critical Illness


subject: CHEBI:50744

subject_name: citrate salt


subject: MESH:D002951

subject_name: Citrates


subject: CHEBI:133748

subject_name: citrate anion


subject: CHEBI:30769

subject_name: Citric acid


subject: CHEBI:2781

subject_name: Apocynin

object_name: chronic obstructive pulmonary disease


subject: CHEBI:68841

subject_name: Gadobutrol

object_name: renal artery obstruction


subject: UMLS:C0388020

subject_name: Gadovist


subject: UMLS:C2713023


subject: UMLS:C5204510

object_name: cancer


subject: UMLS:C5204510

object_name: neoplasm


subject: GTOPDB:12907

subject_name: bexmarilimab


subject: GTOPDB:12907


subject: CHEMBL.COMPOUND:CHEMBL4594544

subject_name: BEXMARILIMAB


subject: CHEMBL.COMPOUND:CHEMBL4594544


subject: CHEBI:87681

subject_name: Ranolazine

object_name: long QT syndrome 3


subject: CHEBI:87681

object_name: Long QT syndrome type 3


subject: UNII:DWN2WN457X

subject_name: Dexamethasone acetate monohydrate

object_name: Metastatic malignant neoplasm to bone


subject: PUBCHEM.COMPOUND:3680

subject_name: Dexamethasone acetate


subject: CHEBI:15765

subject_name: Levodopa

object_name: Stroke (heart beat)


subject: CHEBI:15765

object_name: Stroke, CTCAE


subject: CHEBI:15765

object_name: Broca's Aphasia


subject: CHEBI:3395

subject_name: carbidopa

object_name: stroke disorder


subject: CHEBI:3395

object_name: cerebrovascular disorder


subject: CHEBI:3395


subject: CHEBI:3395


subject: CHEBI:3395


subject: CHEBI:94430

subject_name: DL-Carbidopa


subject: CHEBI:94430


subject: CHEBI:94430


subject: CHEBI:94430


subject: CHEBI:94430


subject: CHEBI:39585

subject_name: Carbidopa


subject: CHEBI:39585


subject: CHEBI:39585


subject: CHEBI:39585


subject: CHEBI:39585


subject: CHEBI:94366

subject_name: itraconazole

object_name: Adverse drug interaction


subject: PUBCHEM.COMPOUND:12043008

subject_name: Stribild

object_name: Human immunodeficiency virus II infection


subject: PUBCHEM.COMPOUND:23083982

subject_name: Elvitegravir


subject: PUBCHEM.COMPOUND:24950485

subject_name: Cobicistat


subject: PUBCHEM.COMPOUND:54214995

subject_name: Sacubitril

object_name: coronary artery disorder


subject: PUBCHEM.COMPOUND:54214995

object_name: coronary atherosclerosis


subject: PUBCHEM.COMPOUND:54214995

object_name: Ischaemic mitral regurgitation


subject: CHEBI:9927

subject_name: Valsartan


subject: UMLS:C2703114

object_name: colorectal cancer


subject: UMLS:C2703114

object_name: colorectal carcinoma


subject: UMLS:C2703114

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:3614

subject_name: Chlorhexidine

object_name: Root canal infection


subject: UNII:557S3L3FAP

subject_name: PEMIVIBART


subject: UMLS:C5908975

subject_name: pemivibart


subject: PUBCHEM.COMPOUND:49849451

subject_name: Anacetrapib

object_name: atherosclerosis


subject: UNII:3YEA04NV6H

subject_name: Silatecan

object_name: neoplasm


subject: UMLS:C0961890


subject: UNII:7XL5ISS668

subject_name: Adcetris

object_name: peripheral T-cell lymphoma, not otherwise specified


subject: UNII:7XL5ISS668

object_name: ALK-negative anaplastic large cell lymphoma


subject: UNII:7XL5ISS668

object_name: Stage II Anaplastic Large Cell Lymphoma


subject: UNII:7XL5ISS668

object_name: Stage IV Anaplastic Large Cell Lymphoma


subject: UNII:7XL5ISS668

object_name: Stage III Anaplastic Large Cell Lymphoma


subject: UMLS:C1832035


subject: UMLS:C1832035


subject: UMLS:C1832035


subject: UMLS:C1832035


subject: UMLS:C1832035


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:64816

object_name: ALK-positive anaplastic large cell lymphoma


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:4911


subject: CHEBI:4911


subject: PUBCHEM.COMPOUND:16760419

subject_name: Etoposide phosphate

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: PUBCHEM.COMPOUND:16760419


subject: PUBCHEM.COMPOUND:16760419

object_name: hepatosplenic T-cell lymphoma


subject: PUBCHEM.COMPOUND:16760419


subject: PUBCHEM.COMPOUND:16760419

object_name: enteropathy-associated T-cell lymphoma


subject: PUBCHEM.COMPOUND:16760419

object_name: angioimmunoblastic T-cell lymphoma


subject: PUBCHEM.COMPOUND:16760419


subject: PUBCHEM.COMPOUND:16760419

object_name: adult T-cell leukemia/lymphoma


subject: PUBCHEM.COMPOUND:16760419

object_name: mature T-cell and NK-cell non-Hodgkin lymphoma


subject: PUBCHEM.COMPOUND:16760419


subject: PUBCHEM.COMPOUND:16760419


subject: PUBCHEM.COMPOUND:16760419


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:8382


subject: CHEBI:8382


subject: PUBCHEM.COMPOUND:16130933

subject_name: SOVATELITIDE

object_name: Acute cerebral ischemia


subject: PUBCHEM.COMPOUND:18007905

subject_name: Sovateltide


subject: UNII:11X778QIZS

subject_name: sovateltide


subject: UMLS:C2348442


subject: PUBCHEM.COMPOUND:71696703

object_name: myeloproliferative neoplasm


subject: PUBCHEM.COMPOUND:71696703

object_name: Malignant myeloproliferative neoplasm


subject: PUBCHEM.COMPOUND:71696703

object_name: Myelodysplasia


subject: PUBCHEM.COMPOUND:71696703

object_name: acute leukemia


subject: PUBCHEM.COMPOUND:71696703

object_name: adult lymphoma


subject: PUBCHEM.COMPOUND:71696703

object_name: lymphoma


subject: PUBCHEM.COMPOUND:71696703

object_name: pediatric lymphoma


subject: UMLS:C5666845

subject_name: Aurora A Kinase Inhibitor VIC-1911


subject: UMLS:C5666845


subject: UMLS:C5666845


subject: UMLS:C5666845


subject: UMLS:C5666845


subject: UMLS:C5666845


subject: UMLS:C5666845


subject: CHEBI:3757

subject_name: Clonidine

object_name: Vasospasm


subject: UNII:7D0YB67S97

subject_name: Abatacept

object_name: hematopoietic and lymphoid cell neoplasm


subject: UNII:7D0YB67S97

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: UMLS:C0378942


subject: UMLS:C0378942


subject: CHEBI:28834

object_name: Postoperative Pain, Acute


subject: UMLS:C4305918


subject: CHEBI:7772

subject_name: omeprazole

object_name: Upper airway resistance syndrome


subject: CHEBI:7772

object_name: obstructive sleep apnea syndrome


subject: CHEBI:77260

subject_name: Omeprazole


subject: CHEBI:77260


subject: CHEBI:49900

subject_name: Arsenous acid

object_name: lung cancer


subject: CHEBI:49900

object_name: lung neoplasm


subject: CHEBI:49900

object_name: lung carcinoma


subject: PUBCHEM.COMPOUND:518740

subject_name: Arsenic trioxide


subject: PUBCHEM.COMPOUND:518740


subject: PUBCHEM.COMPOUND:518740


subject: CHEBI:30621

subject_name: diarsenic trioxide


subject: CHEBI:30621


subject: CHEBI:30621


subject: UNII:S7V92P67HO


subject: UNII:S7V92P67HO


subject: UNII:S7V92P67HO


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Branch retinal vein occlusion


subject: CHEBI:74947

subject_name: Thalidomide

object_name: Recurrent Grade 3 Follicular Lymphoma


subject: UMLS:C2698155

subject_name: Icrucumab

object_name: Childhood Breast Carcinoma


subject: UMLS:C2698155

object_name: breast carcinoma


subject: UMLS:C2698155

object_name: breast cancer


subject: UMLS:C3853885

object_name: endometrium neoplasm


subject: CHEBI:28887

subject_name: Ofatumumab

object_name: Mantle cell lymphoma recurrent


subject: CHEBI:28887

object_name: Recurrent Adult Diffuse Large Cell Lymphoma


subject: CHEBI:28887

object_name: Recurrent Grade 2 Follicular Lymphoma


subject: CHEBI:28887

object_name: Recurrent Grade 1 Follicular Lymphoma


subject: CHEBI:28887


subject: UMLS:C1541395


subject: UMLS:C1541395


subject: UMLS:C1541395


subject: UMLS:C1541395


subject: UMLS:C1541395


subject: UNII:I031V2H011

subject_name: Tocilizumab

object_name: macrophage activation syndrome


subject: UNII:VXT8SZ6875


subject: UNII:VXT8SZ6875


subject: UNII:VXT8SZ6875


subject: CHEBI:9168

subject_name: Sirolimus

object_name: dry eye syndrome


subject: CHEBI:9168

object_name: Dry Eye, CTCAE


subject: CHEBI:9168

object_name: Dryness of eye


subject: CHEBI:6456

subject_name: Lidocaine

object_name: Intubation complication


subject: CHEBI:6456

object_name: Failed or difficult intubation


subject: UNII:2Y3T5IF01Z

subject_name: Retifanlimab

object_name: melanoma


subject: UMLS:C4688466

subject_name: INCMGA 0012


subject: CHEBI:8382

subject_name: Prednisone

object_name: Miller-Dieker lissencephaly syndrome


subject: CHEBI:8382

object_name: myoclonic dystonia 11


subject: MESH:D000082082

subject_name: Immune Checkpoint Inhibitors

object_name: Disseminated Malignant Neoplasm


subject: MESH:D000082082

object_name: Embolism, Tumor


subject: MESH:D000082082

object_name: Neoplasm Metastasis


subject: CHEBI:37924

subject_name: Atazanavir

object_name: Osteopenia


subject: CHEBI:45409

subject_name: Ritonavir


subject: CHEBI:6339

subject_name: Etoricoxib

object_name: Ectopic ossification


subject: UMLS:C1530229

subject_name: Arcoxia


subject: UNII:C79B5A73C4

object_name: cancer


subject: UNII:C79B5A73C4

object_name: neoplasm


subject: UMLS:C3640131


subject: UMLS:C3640131


subject: PUBCHEM.COMPOUND:23594367

subject_name: Boceprevir

object_name: thrombocytopenia


subject: CHEBI:68595

subject_name: Telaprevir


subject: CHEBI:31905

subject_name: Nicorandil

object_name: diabetes mellitus


subject: CHEBI:31905

object_name: angina unstable


subject: CHEBI:49668

subject_name: Gefitinib

object_name: small cell lung carcinoma


subject: CHEBI:8869

subject_name: Risedronic acid

object_name: Prosthesis Loosening


subject: UNII:ST9B0EMC0H

object_name: Childhood Breast Carcinoma


subject: UNII:ST9B0EMC0H

object_name: breast carcinoma


subject: UNII:ST9B0EMC0H

object_name: breast cancer


subject: CHEMBL.COMPOUND:CHEMBL4297758


subject: CHEMBL.COMPOUND:CHEMBL4297758


subject: CHEMBL.COMPOUND:CHEMBL4297758


subject: UNII:6XHD59349R

subject_name: POMOTRELVIR


subject: CHEBI:30742

subject_name: macrogol

object_name: Dry Eye, CTCAE


subject: CHEBI:30742

object_name: Dryness of eye


subject: CHEBI:6456

object_name: abortion


subject: CHEBI:6456

object_name: Induced Abortion Finding


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: Treatment Resistant Disorders


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C5400115

subject_name: Cisplatin Liquid Injection

object_name: urothelial carcinoma


subject: UMLS:C5400115

object_name: transitional cell carcinoma


subject: CHEBI:15367

subject_name: Tretinoin

object_name: Malignant neoplasm of colon stage IV


subject: CHEBI:15367

object_name: Rectal cancer stage IV


subject: PUBCHEM.COMPOUND:2307

subject_name: Andion

object_name: vitiligo-associated multiple autoimmune disease susceptibility 1


subject: PUBCHEM.COMPOUND:2307

object_name: vitiligo


subject: CHEBI:3001

subject_name: beclomethasone


subject: CHEBI:3001


subject: MESH:D012462

subject_name: Saline Solution, Hypertonic

object_name: Right ventricular failure


subject: MESH:D012462

object_name: Hypovolemia


subject: CHEBI:73604

subject_name: Lys-Gly


subject: CHEBI:73604


subject: CHEBI:90001

subject_name: cystathionine ketimine

object_name: oropharynx squamous cell carcinoma


subject: CHEBI:28082


subject: UMLS:C3813556

subject_name: Cancer/Testis Antigen


subject: PR:000050337

subject_name: mature calcitonin


subject: CHEMBL.COMPOUND:CHEMBL2109386

subject_name: CHTNT-1 131I

object_name: glioblastoma


subject: CHEMBL.COMPOUND:CHEMBL2109386

object_name: Brain Stem Glioblastoma


subject: CHEMBL.COMPOUND:CHEMBL2109386

object_name: glioma susceptibility 1


subject: UMLS:C0879273

subject_name: Cotara


subject: UMLS:C0879273


subject: UMLS:C0879273


subject: UNII:U9T63BZ3AS

object_name: bacterial infectious disease


subject: CHEBI:16576

subject_name: D-alanyl-D-alanine

object_name: psoriatic arthritis


subject: CHEBI:195181

subject_name: Alanylalanine


subject: UMLS:C0051078

subject_name: alanylalanine


subject: UMLS:C0360513

subject_name: testosterone patch

object_name: Stress urinary incontinence


subject: UMLS:C5238406

subject_name: p97 Inhibitor CB-5339

object_name: Myelodysplasia


subject: UMLS:C5238406

object_name: Relapsing acute myeloid leukemia


subject: CHEBI:233453

object_name: herpes labialis


subject: CHEBI:35854

subject_name: Valaciclovir


subject: CHEBI:10119

subject_name: Ziprasidone

object_name: panic disorder


subject: CHEBI:10119

object_name: panic disorder 1


subject: CHEBI:4636

subject_name: Diphenhydramine

object_name: endogenous depression


subject: CHEBI:4636

object_name: major depressive disorder


subject: UNII:AIS8N3O50B

subject_name: Seltorexant


subject: UMLS:C5139948


subject: UMLS:C0594372

subject_name: Avonex

object_name: ulcerative colitis


subject: UMLS:C0594372

object_name: inflammatory bowel disease 1


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel

object_name: skin squamous cell carcinoma


subject: MESH:C520255

object_name: cutaneous squamous cell carcinoma


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: CHEBI:49668

subject_name: Gefitinib

object_name: Untreated Childhood Brain Stem Glioma


subject: CHEBI:49668

object_name: Untreated Childhood Giant Cell Glioblastoma


subject: CHEBI:49668

object_name: Untreated Childhood Gliomatosis Cerebri


subject: CHEBI:49668

object_name: Untreated Childhood Gliosarcoma


subject: CHEBI:49668

object_name: Untreated Childhood Glioblastoma


subject: CHEBI:49668

object_name: Untreated Childhood Oligodendroglioma


subject: CHEBI:49668

object_name: Untreated Childhood Anaplastic Oligodendroglioma


subject: CHEBI:49668

object_name: Untreated Childhood Anaplastic Astrocytoma


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: schistosomiasis


subject: CHEBI:39465

subject_name: timolol

object_name: anterior ischemic optic neuropathy


subject: MESH:D007651

subject_name: Keto Acids

object_name: type 2 diabetes mellitus


subject: MESH:D007651

object_name: Insulin resistance


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin

object_name: acute myeloid leukemia by FAB classification


subject: UNII:M89N0Q7EQR

object_name: Elevated WT1


subject: UNII:M89N0Q7EQR

object_name: EBV-Positive Neoplastic Cells Present


subject: UNII:M89N0Q7EQR

object_name: Blasts Under 5 Percent of Bone Marrow Nucleated Cells


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: UMLS:C3853898

object_name: acute leukemia


subject: CHEMBL.COMPOUND:CHEMBL2109608

object_name: keratoacanthoma


subject: CHEMBL.COMPOUND:CHEMBL2109608

object_name: squamous cell carcinoma


subject: CHEMBL.COMPOUND:CHEMBL2109608

object_name: trabecular adenocarcinoma


subject: CHEMBL.COMPOUND:CHEMBL2109608

object_name: cutaneous neuroendocrine carcinoma


subject: CHEMBL.COMPOUND:CHEMBL2109608

object_name: Kaposi Sarcoma


subject: UMLS:C2983744

subject_name: Darleukin


subject: UMLS:C2983744


subject: UMLS:C2983744


subject: UMLS:C2983744


subject: UMLS:C2983744


subject: UMLS:C1511014

subject_name: BIBH 1

object_name: colorectal neoplasm


subject: UMLS:C3896769

subject_name: Anti-EGFR Monoclonal Antibody SCT200

object_name: triple-negative breast carcinoma


subject: CHEBI:144094

subject_name: bicalutamide

object_name: metabolic dysfunction-associated steatotic liver disease


subject: CHEBI:144094

object_name: Androgen excess


subject: CHEBI:31943

subject_name: Oxatomide

object_name: Duchenne muscular dystrophy


subject: UMLS:C0145958

subject_name: Tinset


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: Physical trauma


subject: CHEBI:3215

object_name: Injury


subject: CHEBI:3215

object_name: Trauma


subject: CHEBI:3215

object_name: TRAUMA/INJURY PROBLEM


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:64816


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:4911

object_name: Ph-positive acute lymphoblastic leukemia


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: UNII:3A58010674

subject_name: Pegfilgrastim

object_name: lymphoblastic lymphoma


subject: UNII:3A58010674

object_name: Adult Lymphoblastic Lymphoma


subject: UNII:3A58010674

object_name: Childhood Lymphoblastic Lymphoma


subject: UNII:3A58010674


subject: UNII:3A58010674

object_name: Childhood B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1


subject: UNII:3A58010674


subject: CHEBI:78543

subject_name: Ponatinib


subject: CHEBI:8382

subject_name: Prednisone


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UMLS:C0295415

subject_name: rituximab


subject: CHEBI:143658


subject: CHEBI:28445

subject_name: vincristine


subject: UMLS:C3640130

object_name: gastric adenocarcinoma


subject: UMLS:C1871984

object_name: Seizure Related to COVID-19


subject: UMLS:C1871984

object_name: visual epilepsy


subject: CHEBI:90225

subject_name: Rubitecan

object_name: colorectal cancer


subject: CHEBI:90225

object_name: colorectal carcinoma


subject: CHEBI:90225

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C0813973

subject_name: Medical Marijuana

object_name: Presenile dementia


subject: UMLS:C0813973

object_name: dementia


subject: UMLS:C0813973

object_name: Alzheimer disease type 1


subject: UMLS:C0813973

object_name: Alzheimer disease


subject: UMLS:C0813973

object_name: Agitation


subject: PUBCHEM.COMPOUND:129130827

subject_name: Bictegravir

object_name: abdominal obesity-metabolic syndrome


subject: UNII:1FQ2RY5YHH

subject_name: Patiromer

object_name: kidney failure


subject: UniProtKB:P38507

subject_name: SPA_STAAU Immunoglobulin G-binding protein A (sprot)

object_name: Stomach cancer


subject: UniProtKB:P38507

object_name: gastric cancer


subject: UniProtKB:P0A015

subject_name: SPA_STAAM Immunoglobulin G-binding protein A (sprot)


subject: UniProtKB:P0A015


subject: PR:000029158

subject_name: immunoglobulin G-binding protein A


subject: PR:000029158


subject: UniProtKB:P99134

subject_name: SPA_STAAN Immunoglobulin G-binding protein A (sprot)


subject: UniProtKB:P99134


subject: UNII:85KUE857XM

subject_name: SHR-1258 dimaleate

object_name: HER2 positive breast carcinoma


subject: UMLS:C5206643

subject_name: Pyrotinib Dimaleate


subject: CHEBI:70746

subject_name: Dabigatran etexilate

object_name: Anticoagulant adverse reaction


subject: CHEBI:70752

subject_name: Dabigatran


subject: CHEBI:72296

subject_name: Apixaban


subject: CHEBI:85974

subject_name: edoxaban tosylate hydrate

object_name: Ischemic stroke


subject: CHEBI:85974


subject: PUBCHEM.COMPOUND:11635624

subject_name: Edoxaban


subject: CHEBI:32314

subject_name: Geodon

object_name: Acute mania


subject: CHEBI:32314

object_name: Manic Disorder


subject: CHEBI:10119

subject_name: Ziprasidone


subject: CHEBI:10119


subject: UNII:TC549UFL8P

object_name: Cirrhosis


subject: UNII:TC549UFL8P

object_name: liver cirrhosis


subject: UNII:TC549UFL8P

object_name: Cognitive impairment


subject: UMLS:C1831848


subject: UMLS:C1831848


subject: UMLS:C1831848


subject: UMLS:C4687472

subject_name: PCV mRNA-4157

object_name: melanoma


subject: UNII:3A58010674

subject_name: Pegfilgrastim

object_name: colon carcinoma


subject: UNII:3A58010674

object_name: colon cancer


subject: UNII:3A58010674

object_name: rectal carcinoma


subject: UNII:3A58010674

object_name: rectal cancer


subject: UNII:3A58010674

object_name: Childhood Rectal Carcinoma


subject: PUBCHEM.COMPOUND:4473760

subject_name: Combivir

object_name: HIV infection


subject: RXCUI:192254


subject: CHEBI:50853

subject_name: quantum dot

object_name: HIV-1 infection


subject: CHEBI:50853

object_name: fibromyalgia


subject: CHEBI:36796

subject_name: duloxetine


subject: UMLS:C0758491

subject_name: JL1 antigen

object_name: acute lymphoblastic leukemia


subject: CHEBI:26710

subject_name: Sodium chloride

object_name: non-Hodgkin lymphoma


subject: UNII:9013DUQ28K

subject_name: Anakinra

object_name: Blepharokeratoconjunctivitis


subject: UMLS:C1704264

subject_name: Interleukin 1 Receptor Antagonist Protein


subject: PR:000001137

subject_name: interleukin-1 receptor antagonist protein


subject: CHEBI:42797

subject_name: Gabapentin

object_name: Urinary Urgency


subject: CHEBI:42797

object_name: Urinary Urgency, CTCAE


subject: CHEBI:42797

object_name: Incontinence


subject: CHEBI:42797

object_name: Pollakisuria


subject: CHEBI:42797

object_name: Urinary Frequency, CTCAE


subject: CHEBI:42797

object_name: Nocturia


subject: UNII:9X7O8V25IT

subject_name: collagenase

object_name: familial multiple lipomatosis


subject: UNII:9X7O8V25IT

object_name: lipoma


subject: UMLS:C0009053

subject_name: collagenase Clostridium histolyticum


subject: UMLS:C0009053


subject: CHEBI:48923

subject_name: erythromycin

object_name: asthma


subject: CHEBI:42355

subject_name: Erythromycin


subject: MESH:C568829

object_name: congenital disorder of deglycosylation


subject: MESH:C568829

object_name: congenital disorder of deglycosylation 1


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: maturity-onset diabetes of the young type 1


subject: CHEBI:39548

object_name: RENAL FAILURE CHRONIC REQUIRING HEMODIALYSIS


subject: CHEBI:17026

subject_name: Progesterone

object_name: stroke disorder


subject: CHEBI:17026

object_name: cerebrovascular disorder


subject: CHEBI:17026

object_name: Stroke (heart beat)


subject: CHEBI:17026

object_name: Stroke, CTCAE


subject: UMLS:C2757070

subject_name: Progesterone [EPC]


subject: UMLS:C2757070


subject: UMLS:C2757070


subject: UMLS:C2757070


subject: CHEBI:3732

subject_name: Clarithromycin

object_name: Chronic lung disease


subject: UMLS:C3484407

subject_name: Ambrosia artemisiifolia extract

object_name: Atopic rhinitis


subject: UMLS:C3484407

object_name: Allergic Rhinitis, CTCAE


subject: DRUGBANK:DB10385

subject_name: Ambrosia artemisiifolia pollen


subject: DRUGBANK:DB10385


subject: CHEBI:10033

subject_name: Warfarin

object_name: Drug Interactions


subject: CHEBI:8707

subject_name: Quetiapine

object_name: attention deficit hyperactivity disorder, inattentive type


subject: CHEBI:10023

subject_name: Voriconazole

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:4932

subject_name: Eupatilin

object_name: NSAID-associated gastropathy


subject: CHEBI:4932

object_name: Non-steroidal anti-inflammatory drug-induced enteropathy


subject: CHEBI:4932

object_name: enteritis


subject: CHEBI:4932

object_name: Other musculoskeletal disorder


subject: CHEBI:4932

object_name: ankylosing spondylitis


subject: CHEBI:4932

object_name: rheumatoid arthritis


subject: CHEBI:4932

object_name: gastric ulcer


subject: CHEBI:4932

object_name: Gastric Ulcer, CTCAE


subject: CHEBI:4932

object_name: osteoarthritis


subject: UMLS:C1831930

object_name: prostate carcinoma


subject: UMLS:C1831930

object_name: prostate cancer


subject: CHEBI:47657

subject_name: Roflumilast

object_name: peripheral nervous system disorder


subject: CHEBI:47657

object_name: neuropathy


subject: CHEBI:135349

subject_name: Mitiglinide

object_name: Diabetes


subject: CHEBI:135349

object_name: diabetes mellitus


subject: CHEBI:70839

subject_name: Dasatinib

object_name: mild neurocognitive disorder


subject: CHEBI:70839

object_name: mild cognitive impairment


subject: CHEBI:70839

object_name: Alzheimer Disease, Early Onset


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:57694


subject: CHEBI:16243

subject_name: Quercetin


subject: CHEBI:6456

subject_name: Lidocaine

object_name: Needle phobia


subject: UNII:AHU547PI9H

subject_name: Ferric derisomaltose

object_name: Acute Heart Failure Related to COVID-19


subject: UNII:AHU547PI9H

object_name: Acute heart failure


subject: UNII:AHU547PI9H

object_name: Heart failure with reduced ejection fraction


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: cancer pain


subject: CHEBI:76607

subject_name: Macitentan

object_name: Digital ulcer


subject: PUBCHEM.COMPOUND:44424639

subject_name: Vinorelbine

object_name: malignant pleural mesothelioma


subject: CHEBI:93786


subject: CHEBI:36005

subject_name: docosahexaenoic acid

object_name: Head Injury


subject: CHEBI:28125

subject_name: Doconexent


subject: CHEBI:16016

subject_name: Glycerone


subject: CHEBI:28689

subject_name: Prasterone


subject: UMLS:C1134588

object_name: Adult Myelodysplastic Syndrome


subject: UMLS:C1134588

object_name: childhood myelodysplastic syndrome


subject: UMLS:C1134588

object_name: Myelodysplastic Syndrome, CTCAE


subject: CHEMBL.COMPOUND:CHEMBL2109607

object_name: Acne inversa


subject: UMLS:C0350411

subject_name: Oxygen only product in gas for inhalation

object_name: pulmonary embolism


subject: UNII:CUJ2MVI71Y

subject_name: Daclizumab

object_name: anterior uveitis


subject: UNII:CUJ2MVI71Y

object_name: juvenile idiopathic arthritis


subject: UNII:CUJ2MVI71Y

object_name: iritis


subject: UNII:CUJ2MVI71Y

object_name: Immunosuppression


subject: UNII:CUJ2MVI71Y

object_name: Decreased Immunologic Activity [PE]


subject: UMLS:C0281549

subject_name: Zenapax


subject: UMLS:C0281549


subject: UMLS:C0281549


subject: UMLS:C0281549


subject: UMLS:C0281549


subject: CHEMBL.COMPOUND:CHEMBL4594480

object_name: non-small cell lung carcinoma


subject: UMLS:C3896827

subject_name: Anti-CEACAM6 AFAIKL2 Antibody Fragment/Jack Bean Urease Immunoconjugate L-DOS47


subject: CHEBI:50634

object_name: Vasospasm


subject: CHEBI:50634

object_name: Acute Stroke


subject: CHEBI:27690

subject_name: Acetazolamide


subject: CHEBI:27690


subject: PUBCHEM.COMPOUND:133604

subject_name: Collagen

object_name: myostatin-related muscle hypertrophy


subject: PUBCHEM.COMPOUND:133604

object_name: Skeletal muscle hypertrophy


subject: KEGG.COMPOUND:C00211


subject: KEGG.COMPOUND:C00211


subject: CHEBI:3815


subject: CHEBI:3815


subject: UMLS:C0009325

subject_name: collagen


subject: UMLS:C0009325


subject: CHEBI:74705

subject_name: Met-Leu

object_name: effect increased


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: CHEBI:50731

subject_name: morphine sulfate pentahydrate

object_name: Femur fracture


subject: CHEBI:232328

subject_name: Dordaviprone

object_name: glioblastoma


subject: CHEBI:232328

object_name: Childhood Glioblastoma


subject: CHEBI:232328

object_name: adult glioblastoma


subject: UMLS:C3827072


subject: UMLS:C3827072


subject: UMLS:C3827072


subject: CHEBI:41423

subject_name: Celecoxib

object_name: spinal muscular atrophy


subject: CHEBI:6959

subject_name: Mivacurium chloride

object_name: Emergencies


subject: UNII:600ZG213C3

subject_name: MIVACURIUM CHLORIDE


subject: CHEBI:6958

subject_name: Mivacurium


subject: DRUGBANK:DB17579

object_name: neoplasm


subject: CHEBI:63632

subject_name: Topotecan

object_name: tumor of meninges


subject: UNII:N824AOU5XV

subject_name: Pegvisomant

object_name: partial lipodystrophy


subject: PUBCHEM.COMPOUND:2307

subject_name: Andion

object_name: eosinophilic esophagitis


subject: PUBCHEM.COMPOUND:2307

object_name: Eosinophilic infiltration of the esophagus


subject: CHEBI:3001

subject_name: beclomethasone


subject: CHEBI:3001


subject: UNII:658876KMFP

object_name: B-cell chronic lymphocytic leukemia


subject: UNII:W5H7E45YT3

subject_name: Banoxantrone


subject: CHEBI:176381

subject_name: Diosmin

object_name: rheumatoid arthritis


subject: UNII:EEM82VOY7C

subject_name: chlorophyllin

object_name: rectal neoplasm


subject: PUBCHEM.COMPOUND:92043599

subject_name: epoetin alfa

object_name: middle cerebral artery infarction


subject: PUBCHEM.COMPOUND:92043599

object_name: Acute Stroke


subject: UNII:7T1PY32ZPH

subject_name: Cirtuvivint

object_name: acute myeloid leukemia by FAB classification


subject: UNII:7T1PY32ZPH

object_name: acute myeloid leukemia


subject: UNII:7T1PY32ZPH

object_name: Myelodysplasia


subject: UNII:7T1PY32ZPH

object_name: Adult Myelodysplastic Syndrome


subject: UNII:7T1PY32ZPH

object_name: childhood myelodysplastic syndrome


subject: UNII:7T1PY32ZPH

object_name: Myelodysplastic Syndrome, CTCAE


subject: UNII:7T1PY32ZPH

object_name: Recurrent Myelodysplastic Syndrome


subject: UNII:7T1PY32ZPH

object_name: Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes


subject: UNII:7T1PY32ZPH

object_name: Recurrent Acute Myeloid Leukemia


subject: UNII:7T1PY32ZPH

object_name: Refractory Myelodysplastic Syndrome


subject: UNII:7T1PY32ZPH

object_name: Refractory acute myeloid leukemia


subject: UNII:39IS23Q1EW

subject_name: Cedazuridine


subject: UNII:39IS23Q1EW


subject: UNII:39IS23Q1EW


subject: UNII:31M3WLJ3KG

subject_name: Belvarafenib

object_name: melanoma


subject: PUBCHEM.COMPOUND:54556623

subject_name: Zabofloxacin

object_name: chronic obstructive pulmonary disease


subject: UMLS:C5222403

subject_name: Amiodarone Hydrochloride Liquid Injection

object_name: cardiac arrest


subject: UMLS:C5222403

object_name: Cardiac Arrest, CTCAE


subject: UMLS:C3827183

subject_name: Oncorine

object_name: liver carcinoma


subject: GTOPDB:13805

subject_name: batoclimab

object_name: Graves disease


subject: UNII:C98V9UMX3D

subject_name: BATOCLIMAB


subject: UMLS:C5419322

subject_name: Batoclimab


subject: CHEBI:46058

subject_name: TAXOTERE


subject: MESH:C575718

object_name: Metastatic malignant neoplasm to pancreas


subject: UMLS:C3274907


subject: CHEBI:231598

subject_name: Tazemetostat

object_name: nerve sheath neoplasm


subject: UMLS:C3491293

object_name: Complicated intra-abdominal infection


subject: PUBCHEM.COMPOUND:76211403

subject_name: Eravacycline


subject: UMLS:C5690369

subject_name: ChAd63 Pfs25-IMX313 malaria vaccine

object_name: malaria


subject: UMLS:C5690370

subject_name: MVA Pfs25-IMX313 malaria vaccine


subject: UMLS:C5814624

subject_name: SEL 037

object_name: Hyperuricemia


subject: UMLS:C5814624

object_name: Hyperuricemia, CTCAE


subject: UMLS:C5814624

object_name: Chronic gouty arthritis


subject: UMLS:C5814625


subject: UMLS:C5814625


subject: UMLS:C4688008

subject_name: Synthetic Vaccine Particles-Rapamycin


subject: UMLS:C4688008


subject: UMLS:C4688008


subject: UMLS:C4688609

subject_name: SEL 110


subject: UMLS:C4688609


subject: UMLS:C4688609


subject: UMLS:C4723834

subject_name: CVac

object_name: Pancreatic carcinoma stage II


subject: UMLS:C4723834

object_name: Pancreatic carcinoma stage I


subject: UNII:T1IV236CVP

object_name: psoriasis


subject: UNII:T1IV236CVP

object_name: arthritis


subject: UNII:T1IV236CVP

object_name: Arthritis, CTCAE


subject: PUBCHEM.COMPOUND:137706467

subject_name: Rimiducid

object_name: Recurrent Chronic Lymphoid Leukemia


subject: PUBCHEM.COMPOUND:137706467

object_name: Acute lymphoblastic leukemia recurrent


subject: PUBCHEM.COMPOUND:137706467

object_name: Recurrent Acute Myeloid Leukemia


subject: PUBCHEM.COMPOUND:137706467

object_name: acute biphenotypic leukemia in relapse


subject: PUBCHEM.COMPOUND:137706467

object_name: Recurrent Myelodysplastic Syndrome


subject: PUBCHEM.COMPOUND:137706467

object_name: Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes


subject: PUBCHEM.COMPOUND:137706467

object_name: Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm


subject: PUBCHEM.COMPOUND:137706467

object_name: Recurrent Chronic Myelomonocytic Leukemia


subject: PUBCHEM.COMPOUND:137706467

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: PUBCHEM.COMPOUND:137706467


subject: PUBCHEM.COMPOUND:137706467

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: PUBCHEM.COMPOUND:137706467

object_name: myeloproliferative neoplasm


subject: PUBCHEM.COMPOUND:137706467

object_name: Malignant myeloproliferative neoplasm


subject: PUBCHEM.COMPOUND:137706467

object_name: bilineal acute myeloid leukemia


subject: CHEMBL.COMPOUND:CHEMBL3989979

subject_name: RIVOGENLECLEUCEL


subject: CHEMBL.COMPOUND:CHEMBL3989979


subject: CHEMBL.COMPOUND:CHEMBL3989979


subject: CHEMBL.COMPOUND:CHEMBL3989979


subject: CHEMBL.COMPOUND:CHEMBL3989979


subject: CHEMBL.COMPOUND:CHEMBL3989979


subject: CHEMBL.COMPOUND:CHEMBL3989979


subject: CHEMBL.COMPOUND:CHEMBL3989979


subject: CHEMBL.COMPOUND:CHEMBL3989979


subject: CHEMBL.COMPOUND:CHEMBL3989979


subject: CHEMBL.COMPOUND:CHEMBL3989979


subject: CHEMBL.COMPOUND:CHEMBL3989979


subject: CHEMBL.COMPOUND:CHEMBL3989979


subject: CHEMBL.COMPOUND:CHEMBL3989979


subject: CHEBI:4910

subject_name: Etomidate

object_name: hypertension


subject: CHEBI:4910

object_name: Hypertension, CTCAE


subject: CHEBI:44915

subject_name: Propofol


subject: CHEBI:44915


subject: UNII:W66XP666AM

subject_name: Voruciclib

object_name: diffuse large B-cell lymphoma


subject: UNII:W66XP666AM

object_name: B-cell chronic lymphocytic leukemia


subject: UNII:W66XP666AM

object_name: adult acute myeloid leukemia


subject: UNII:W66XP666AM

object_name: childhood acute myeloid leukemia


subject: UNII:W66XP666AM

object_name: acute myeloid leukemia


subject: UNII:DLE8519RWM

subject_name: ENFORTUMAB

object_name: Metastatic Malignant Solid Neoplasm


subject: UMLS:C3896914


subject: PUBCHEM.COMPOUND:156963654

subject_name: Sacituzumab govitecan


subject: PUBCHEM.COMPOUND:156963654

object_name: Advanced Malignant Solid Neoplasm


subject: RXCUI:2566308

subject_name: 0.5 ML Streptococcus pneumoniae serotype 1 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 10A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 11A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 12F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 15B capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 18C capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 19A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 19F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 22F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 23F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 3 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 33F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 4 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 5 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 6A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 6B capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0088 MG/ML / Streptococcus pneumoniae serotype 7F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 8 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 9V capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML Prefilled Syringe


subject: UMLS:C5550571

subject_name: Prevnar 20


subject: MESH:C000726212

object_name: chronic hepatitis B virus infection


subject: MESH:C000726212

object_name: hepatitis B


subject: CHEBI:60648

subject_name: DOXYCYCLINE

object_name: Mansonella perstans Infections


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline


subject: CHEBI:229764

subject_name: Selinexor

object_name: De Novo Myelodysplastic Syndrome


subject: CHEBI:229764

object_name: Secondary Myelodysplastic Syndrome


subject: UNII:C4V974V932

subject_name: Indocyanine green acid form

object_name: adenomyosis


subject: UNII:C4V974V932

object_name: uterine fibroid


subject: UNII:C4V974V932

object_name: Uterine cyst


subject: UNII:C4V974V932

object_name: Endometrial Cyst


subject: CHEBI:49668

subject_name: Gefitinib

object_name: unspecified childhood solid tumor, protocol specific


subject: MESH:D000077203

subject_name: Sodium-Glucose Transporter 2 Inhibitors

object_name: Duchenne muscular dystrophy


subject: UMLS:C3542461

subject_name: Sodium-Glucose Cotransporter 2 Inhibitor [EPC]


subject: CHEBI:23812

subject_name: dimethylmaleic acid

object_name: chronic kidney disease


subject: CHEBI:23812

object_name: Chronic Kidney Disease, CTCAE


subject: UMLS:C0075029

subject_name: spleen fibrinolytic proteinase (human)


subject: UMLS:C0075029


subject: CHEBI:50634

object_name: Chronic Orthostatic Intolerance


subject: CHEBI:50634

object_name: Tachycardia by ECG Finding


subject: CHEBI:50634

object_name: Tachycardia


subject: CHEBI:27690

subject_name: Acetazolamide


subject: CHEBI:27690


subject: CHEBI:27690


subject: CHEBI:127342

subject_name: Atomoxetine


subject: CHEBI:127342


subject: CHEBI:127342


subject: CHEBI:3757

subject_name: Clonidine


subject: CHEBI:3757


subject: CHEBI:3757


subject: CHEBI:4798

subject_name: Entacapone


subject: CHEBI:4798


subject: CHEBI:4798


subject: CHEBI:49662

subject_name: Indomethacin


subject: CHEBI:49662


subject: CHEBI:49662


subject: CHEBI:17632

subject_name: Nitrate


subject: CHEBI:17632


subject: CHEBI:17632


subject: CHEBI:6061

subject_name: Isosorbide dinitrate


subject: CHEBI:6061


subject: CHEBI:6061


subject: CHEBI:6706

subject_name: Mecamylamine


subject: CHEBI:6706


subject: CHEBI:6706


subject: UMLS:C1527137

subject_name: Recombinant melatonin


subject: UMLS:C1527137


subject: UMLS:C1527137


subject: CHEBI:16796

subject_name: Melatonin


subject: CHEBI:16796


subject: CHEBI:16796


subject: CHEBI:6933

subject_name: Midodrine


subject: CHEBI:6933


subject: CHEBI:6933


subject: CHEBI:31859

subject_name: Modafinil


subject: CHEBI:31859


subject: CHEBI:31859


subject: CHEBI:7726

subject_name: octreotide


subject: CHEBI:7726


subject: CHEBI:7726


subject: CHEBI:8499

subject_name: Propranolol


subject: CHEBI:8499


subject: CHEBI:8499


subject: CHEBI:9123

subject_name: Sertraline


subject: CHEBI:9123


subject: CHEBI:9123


subject: CHEBI:64312

subject_name: Memantine


subject: CHEBI:64312


subject: CHEBI:64312


subject: CHEBI:28787

subject_name: Nitroglycerin

object_name: severe pre-eclampsia


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: Iron deficiency


subject: UMLS:C4725178

subject_name: TAFIa Inhibitor DS-1040b

object_name: pulmonary embolism


subject: PUBCHEM.COMPOUND:6096882

subject_name: indocyanine green

object_name: Biliary Colic


subject: PUBCHEM.COMPOUND:6096882

object_name: gallbladder disorder


subject: PUBCHEM.COMPOUND:6096882

object_name: History of - gallbladder disease


subject: UNII:C4V974V932

subject_name: Indocyanine green acid form


subject: UNII:C4V974V932


subject: UNII:C4V974V932


subject: CHEBI:5137

subject_name: fluvastatin sodium

object_name: Childhood Breast Carcinoma


subject: CHEBI:5137

object_name: breast carcinoma


subject: CHEBI:5137

object_name: breast cancer


subject: CHEBI:95159


subject: CHEBI:95159


subject: CHEBI:95159


subject: CHEBI:38562

subject_name: Fluvastatin


subject: CHEBI:38562


subject: CHEBI:38562


subject: PUBCHEM.COMPOUND:2269

object_name: Premature rupture of membranes


subject: UMLS:C0812732

subject_name: INJECTION, AZITHROMYCIN, 500 MG ADMINISTERED


subject: CHEBI:48923

subject_name: erythromycin


subject: CHEBI:42355

subject_name: Erythromycin


subject: CHEBI:73666

subject_name: Thr-Trp

object_name: diabetic kidney disease


subject: CHEBI:5118

subject_name: Fluoxetine

object_name: fibromyalgia


subject: UMLS:C0731349

subject_name: ATG-Fresenius

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C0731349

object_name: acute myeloid leukemia


subject: UMLS:C0731349

object_name: acute lymphoblastic leukemia


subject: MESH:D000961

subject_name: Antilymphocyte Serum


subject: MESH:D000961


subject: MESH:D000961


subject: UMLS:C0003370

subject_name: Antilymphocyte Globulin


subject: UMLS:C0003370


subject: UMLS:C0003370


subject: CHEBI:135041

subject_name: phenbenzamine

object_name: spinal cord injury


subject: CHEBI:4046

subject_name: Cyproheptadine


subject: CHEBI:229652

subject_name: Iptacopan

object_name: age-related macular degeneration


subject: UMLS:C4744992

subject_name: Factor B Inhibitor LNP023


subject: UMLS:C3274703

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: UMLS:C3274703

object_name: stage IV pancreatic cancer


subject: UMLS:C3274703

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: UNII:2PEX5N7DQ4

subject_name: Fevipiprant

object_name: Hepatic impairment


subject: CHEBI:80961


subject: CHEBI:73579

subject_name: Leu-Val


subject: CHEBI:194537

subject_name: Livermorium


subject: UMLS:C1881413

subject_name: Liposome Vesicle


subject: PR:000003915

subject_name: delta-aminolevulinic acid dehydratase


subject: CHEBI:67194

subject_name: Nabiximols

object_name: multiple sclerosis


subject: UMLS:C0876064

subject_name: Lantus

object_name: Type 1 diabetes mellitus with hypoglycemia


subject: UMLS:C0021658

subject_name: Humulin N


subject: CHEBI:16581

subject_name: Pregnenolone

object_name: schizophreniform disorder


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

object_name: Primary malignant neoplasm


subject: UNII:PQX0D8J21J

object_name: childhood malignant neoplasm


subject: UNII:PQX0D8J21J

object_name: Malignant obstetric neoplasm


subject: UMLS:C0879636

subject_name: IMC C225


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C5666968

subject_name: KRAS G12C Inhibitor MK-1084


subject: UMLS:C5666968


subject: UMLS:C5666968


subject: CHEBI:95021

subject_name: pemetrexed


subject: CHEBI:95021


subject: CHEBI:95021


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: GTOPDB:9758

subject_name: camrelizumab

object_name: connective and soft tissue neoplasm


subject: GTOPDB:9758

object_name: Metastatic sarcoma


subject: UNII:73096E137E


subject: UNII:73096E137E


subject: UMLS:C4085979


subject: UMLS:C4085979


subject: PUBCHEM.COMPOUND:70789201

subject_name: Telithromycin

object_name: sinusitis


subject: PUBCHEM.COMPOUND:70789201

object_name: Sinusitis, CTCAE


subject: RXCUI:8375

subject_name: placebo Oral Tablet

object_name: genetic disease


subject: CHEBI:40237

subject_name: Sitagliptin


subject: PUBCHEM.COMPOUND:21183636

subject_name: Atosiban

object_name: female infertility


subject: UMLS:C0078129


subject: UMLS:C3529764

subject_name: HEV 239

object_name: hepatitis E


subject: CHEBI:4672

subject_name: Docetaxel

object_name: Progression of non-small cell lung cancer


subject: CHEBI:230682

subject_name: Indoximod

object_name: non-small cell lung carcinoma


subject: CHEBI:230682


subject: CHEBI:230682

object_name: Non-small cell lung cancer recurrent


subject: UMLS:C4045546


subject: UMLS:C4045546


subject: UMLS:C4045546


subject: CHEMBL.COMPOUND:CHEMBL2108682

subject_name: TERGENPUMATUCEL-L


subject: CHEMBL.COMPOUND:CHEMBL2108682


subject: CHEMBL.COMPOUND:CHEMBL2108682


subject: UNII:YB18NF020M

subject_name: Satralizumab

object_name: myelin oligodendrocyte glycoprotein antibody-associated disease


subject: CHEBI:57858

subject_name: atropinium

object_name: Newborn Encounter Admission Source


subject: CHEBI:57858

object_name: Newborn (finding)


subject: CHEBI:57858

object_name: Premature birth


subject: CHEBI:92712

subject_name: ENDO-ATROPINE


subject: CHEBI:92712


subject: CHEBI:92712


subject: CHEBI:91541


subject: CHEBI:91541


subject: CHEBI:91541


subject: UMLS:C1161352

subject_name: Atropinum, atropine


subject: UMLS:C1161352


subject: UMLS:C1161352


subject: CHEBI:119915

subject_name: Fentanyl


subject: CHEBI:119915


subject: CHEBI:119915


subject: CHEBI:6958

subject_name: Mivacurium


subject: CHEBI:6958


subject: CHEBI:6958


subject: UNII:P76B05O5V6

subject_name: Relugolix

object_name: pregnancy related


subject: UNII:P76B05O5V6

object_name: high-risk pregnancy


subject: UNII:P76B05O5V6

object_name: pregnancy disorder


subject: PUBCHEM.COMPOUND:18772499

subject_name: Inulin

object_name: Nutritional and Metabolic Diseases


subject: PUBCHEM.COMPOUND:18772499

object_name: Bone Diseases, Endocrine


subject: UMLS:C2183198

subject_name: diagnostic drugs renal inulin


subject: UMLS:C2183198


subject: CHEMBL.COMPOUND:CHEMBL2108406

subject_name: EUCALYPTUS OIL


subject: CHEBI:95073

subject_name: Ricolinostat

object_name: adult lymphoma


subject: CHEBI:95073

object_name: lymphoma


subject: CHEBI:95073

object_name: pediatric lymphoma


subject: UMLS:C3272774


subject: UMLS:C3272774


subject: UMLS:C3272774


subject: PUBCHEM.COMPOUND:66766936

subject_name: Cunermuspir

object_name: neuralgia


subject: PUBCHEM.COMPOUND:66766936

object_name: Neuralgia, CTCAE


subject: PUBCHEM.COMPOUND:66766936

object_name: Myalgia, CTCAE


subject: PUBCHEM.COMPOUND:66766936

object_name: Myalgia


subject: UNII:HS69V99BQ2

subject_name: CUNERMUSPIR


subject: UNII:HS69V99BQ2


subject: UNII:HS69V99BQ2


subject: UNII:HS69V99BQ2


subject: CHEBI:94534

subject_name: olanzapine

object_name: Cancer-Associated Anorexia


subject: CHEBI:94534

object_name: Neck Squamous Cell Carcinoma of Unknown Primary


subject: UMLS:C5666916

subject_name: Nebratamig

object_name: non-Hodgkin lymphoma


subject: MESH:D012462

subject_name: Saline Solution, Hypertonic

object_name: Fluid Overload


subject: MESH:D012462

object_name: Hypervolemia


subject: DRUGBANK:DB09106

subject_name: hetastarch


subject: DRUGBANK:DB09106


subject: PUBCHEM.COMPOUND:21879648

subject_name: Abiraterone

object_name: classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency


subject: UMLS:C1170024

subject_name: Adderall-XR

object_name: Depressed mood


subject: UMLS:C1170024

object_name: Cancer patients and suicide and depression


subject: UMLS:C1170024

object_name: Depressed - symptom


subject: UMLS:C1170024

object_name: Depression, CTCAE


subject: UMLS:C1170024

object_name: unspecified childhood solid tumor, protocol specific


subject: UMLS:C1170024

object_name: neurotoxicity


subject: UMLS:C4688623

object_name: B-cell non-Hodgkin lymphoma


subject: UMLS:C4688623

object_name: B-cell neoplasm


subject: UMLS:C4688623


subject: UMLS:C4688623

object_name: mantle cell lymphoma


subject: UMLS:C4688623

object_name: follicular lymphoma


subject: UMLS:C4688623

object_name: diffuse large B-cell lymphoma


subject: UMLS:C5564934

object_name: endometriosis


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Perforated viscus


subject: CHEBI:41879

object_name: Intestinal obstruction and ileus


subject: CHEBI:41879

object_name: Functional disorder


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Inflammatory Response


subject: CHEBI:73604


subject: CHEBI:73604


subject: CHEBI:73604


subject: CHEBI:15365

subject_name: Aspirin

object_name: thrombocytosis


subject: CHEBI:15365

object_name: familial thrombocytosis


subject: CHEBI:15365

object_name: myeloproliferative neoplasm


subject: CHEBI:15365

object_name: bone marrow neoplasm


subject: CHEBI:44423

subject_name: Hydroxyurea


subject: CHEBI:44423


subject: CHEBI:44423


subject: CHEBI:44423


subject: CHEBI:95073

object_name: Carcinoma breast stage IV


subject: CHEBI:95073

object_name: breast carcinoma


subject: UMLS:C3272774


subject: UMLS:C3272774


subject: CHEMBL.COMPOUND:CHEMBL5315004

object_name: ovarian cancer


subject: CHEMBL.COMPOUND:CHEMBL5315004

object_name: ovarian neoplasm


subject: CHEMBL.COMPOUND:CHEMBL5315004

object_name: ovarian carcinoma


subject: CHEMBL.COMPOUND:CHEMBL5315004

object_name: tumor suppressor gene on chromosome 11


subject: CHEMBL.COMPOUND:CHEMBL5315004

object_name: non-small cell lung carcinoma


subject: CHEMBL.COMPOUND:CHEMBL5315004

object_name: lung cancer


subject: UMLS:C5418017

subject_name: Anti-NaPi2b Antibody-drug Conjugate XMT-1592


subject: UMLS:C5418017


subject: UMLS:C5418017


subject: UMLS:C5418017


subject: UMLS:C5418017


subject: UMLS:C5418017


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: Solid Neoplasm


subject: CHEBI:60799

subject_name: Esketamine

object_name: pervasive developmental disorder


subject: CHEBI:60799

object_name: autism


subject: CHEBI:60799

object_name: autism spectrum disorder


subject: UMLS:C3255200

subject_name: aflibercept ophthalmic

object_name: retinal vein occlusion


subject: PUBCHEM.COMPOUND:25127414

object_name: Advanced Lung Adenocarcinoma


subject: UNII:0ICW2LX8AS

subject_name: Bemcentinib


subject: CHEBI:231350

subject_name: Pacritinib


subject: CHEBI:9288

subject_name: Streptozocin

object_name: chronic kidney disease


subject: CHEBI:9288

object_name: Chronic Kidney Disease, CTCAE


subject: CHEBI:33283

subject_name: THIAMINE

object_name: peripheral nervous system disorder


subject: CHEBI:33283

object_name: neuropathy


subject: CHEBI:33283

object_name: Complications of Diabetes Mellitus


subject: UMLS:C3714802

subject_name: Thiamine Drug Class


subject: UMLS:C3714802


subject: UMLS:C3714802


subject: CHEBI:18385

subject_name: Thiamine


subject: CHEBI:18385


subject: CHEBI:18385


subject: UMLS:C1145201

subject_name: INJECTION, PARICALCITOL, 1 MCG

object_name: Stage IIA Rectal Cancer AJCC v7


subject: UMLS:C1145201

object_name: Stage IIA Rectal Cancer AJCC v8


subject: UMLS:C1145201

object_name: stage IIB rectal cancer


subject: UMLS:C1145201

object_name: Stage IIB Rectal Cancer AJCC v7


subject: UMLS:C1145201

object_name: Stage IIB Rectal Cancer AJCC v8


subject: UMLS:C1145201

object_name: Stage IIC Rectal Cancer AJCC v7


subject: UMLS:C1145201

object_name: Stage IIC Rectal Cancer AJCC v8


subject: UMLS:C1145201

object_name: Stage IIIC Rectal Cancer AJCC v7


subject: UMLS:C1145201

object_name: Stage IIIC Rectal Cancer AJCC v8


subject: UMLS:C1145201

object_name: Stage IIIB Rectal Cancer AJCC v8


subject: UMLS:C1145201

object_name: Stage IIIB Rectal Cancer AJCC v7


subject: UMLS:C1145201

object_name: rectum mucinous adenocarcinoma


subject: CHEBI:7931

subject_name: Paricalcitol


subject: CHEBI:7931


subject: CHEBI:7931


subject: CHEBI:7931


subject: CHEBI:7931


subject: CHEBI:7931


subject: CHEBI:7931


subject: CHEBI:7931


subject: CHEBI:7931


subject: CHEBI:7931


subject: CHEBI:7931


subject: CHEBI:7931


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: acute kidney failure


subject: UMLS:C1527137

object_name: Acute Kidney Injury, CTCAE


subject: UMLS:C1527137

object_name: Adverse drug response


subject: CHEBI:16796

subject_name: Melatonin


subject: UNII:3A189DH42V

subject_name: Alemtuzumab

object_name: Congenital Bone Marrow Failure Syndromes


subject: UNII:3A189DH42V

object_name: juvenile idiopathic arthritis


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:44423

subject_name: Hydroxyurea


subject: CHEBI:44423


subject: CHEBI:82339

subject_name: Merphalan


subject: CHEBI:82339


subject: CHEBI:28876

subject_name: Melphalan


subject: CHEBI:28876


subject: CHEBI:9570

subject_name: Thiotepa


subject: CHEBI:9570


subject: CHEBI:66964

subject_name: Dronabinol

object_name: Intrusive memories


subject: UNII:3A3U0GI71G

subject_name: Magnesium oxide

object_name: traumatic encephalopathy


subject: CHEBI:31794

subject_name: magnesium oxide


subject: PUBCHEM.COMPOUND:86217377

subject_name: Oxybutynin AL

object_name: Body odor


subject: CHEBI:144551

subject_name: Oxybutynin


subject: CHEBI:70839

subject_name: Dasatinib

object_name: Metastatic malignant neoplasm to liver


subject: CHEBI:70839

object_name: colon mucinous adenocarcinoma


subject: CHEBI:70839

object_name: colon signet ring cell adenocarcinoma


subject: CHEBI:70839


subject: CHEBI:70839

object_name: rectal signet ring cell adenocarcinoma


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:49375


subject: UNII:GN429E725A

subject_name: Nedisertib

object_name: Adult Solid Neoplasm


subject: UNII:GN429E725A

object_name: Advanced renal cell carcinoma


subject: UMLS:C2348805

subject_name: Topical Gemcitabine Hydrochloride

object_name: endometrial cancer


subject: UMLS:C2348805

object_name: uterine corpus cancer


subject: UMLS:C2348805

object_name: endometrial carcinoma


subject: UMLS:C2348805

object_name: cervical cancer


subject: UMLS:C2348805

object_name: cervical carcinoma


subject: UMLS:C2348805

object_name: ovarian cancer


subject: UMLS:C2348805

object_name: ovarian neoplasm


subject: UMLS:C2348805

object_name: ovarian carcinoma


subject: CHEBI:91414

subject_name: Adavosertib

object_name: childhood malignant neoplasm


subject: UNII:KXG2PJ551I

subject_name: Avelumab


subject: UMLS:C3896806


subject: CHEBI:231342

subject_name: ceralasertib


subject: CHEBI:145374

subject_name: Enasidenib


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus


subject: UNII:YET2XNU791


subject: UMLS:C5418168

subject_name: Fadraciclib


subject: UNII:4B93MGE4AL

subject_name: Futibatinib


subject: GTOPDB:9310

subject_name: lirilumab


subject: UNII:S9XDI9W918

subject_name: LIRILUMAB


subject: UMLS:C3641620


subject: CHEBI:83766

subject_name: Olaparib


subject: UNII:GN429E725A


subject: CHEBI:230905

subject_name: Ribociclib


subject: CHEBI:90227

subject_name: Selumetinib


subject: UNII:0BSC3P4H5X

subject_name: Vistusertib


subject: CHEBI:15365

subject_name: Aspirin

object_name: Drug Interactions


subject: UMLS:C1134696

object_name: Embolism, Tumor


subject: UMLS:C1134696

object_name: Metastatic Lesion


subject: DRUGBANK:DB05014

object_name: acute myeloid leukemia by FAB classification


subject: DRUGBANK:DB05014

object_name: acute myeloid leukemia


subject: CHEBI:40799

subject_name: Boldione

object_name: castration-resistant prostate carcinoma


subject: UMLS:C5854430

subject_name: Anti-GPC3/TCR Nanobody SAR444200

object_name: childhood neoplasm


subject: UMLS:C5854430

object_name: neoplastic syndrome


subject: UMLS:C5854430

object_name: cancer or benign tumor


subject: UMLS:C5854430

object_name: neoplasm


subject: PUBCHEM.COMPOUND:70789204

object_name: Renal transplant failure


subject: PUBCHEM.COMPOUND:70789204

object_name: transplant; complication, rejection


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: CHEBI:61057


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:61049


subject: UNII:D7RD81HE4W

subject_name: thymoglobulin


subject: UNII:D7RD81HE4W


subject: UMLS:C0359156

subject_name: Thymoglobulin


subject: UMLS:C0359156


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: thrombotic thrombocytopenic purpura


subject: CHEBI:28939

object_name: acquired thrombotic thrombocytopenic purpura


subject: CHEBI:28939

object_name: congenital thrombotic thrombocytopenic purpura


subject: UMLS:C5555586

subject_name: Anti-HER2 Monoclonal Antibody QL1209

object_name: Childhood Breast Carcinoma


subject: UMLS:C5555586

object_name: breast carcinoma


subject: UMLS:C5555586

object_name: breast cancer


subject: PUBCHEM.COMPOUND:2307

subject_name: Andion

object_name: perennial allergic rhinitis


subject: CHEBI:3001

subject_name: beclomethasone


subject: PR:000016622

subject_name: tRNA (cytosine-5-)-methyltransferase

object_name: ulcerative colitis


subject: PR:000016622

object_name: inflammatory bowel disease 1


subject: UMLS:C3485429

subject_name: Probiotic Formula

object_name: periodontal disorder


subject: CHEBI:3219

subject_name: Bupropion

object_name: inborn mitochondrial metabolism disorder


subject: CHEBI:3219

object_name: mitochondrial disease


subject: CHEBI:27732

subject_name: Caffeine


subject: CHEBI:27732


subject: CHEBI:146178

subject_name: RACEMETHORPHAN


subject: CHEBI:146178


subject: CHEBI:146176

subject_name: levomethorphan


subject: CHEBI:146176


subject: CHEBI:4470

subject_name: Dextromethorphan


subject: CHEBI:4470


subject: CHEBI:42446

subject_name: Esflurbiprofen


subject: CHEBI:42446


subject: CHEBI:5130

subject_name: Flurbiprofen


subject: CHEBI:5130


subject: UMLS:C5203412

subject_name: Midazolam Liquid Injection


subject: UMLS:C5203412


subject: CHEBI:6931

subject_name: Midazolam


subject: CHEBI:6931


subject: CHEBI:7772

subject_name: omeprazole


subject: CHEBI:7772


subject: CHEBI:77260

subject_name: Omeprazole


subject: CHEBI:77260


subject: CHEBI:8805

subject_name: Repaglinide


subject: CHEBI:8805


subject: PUBCHEM.COMPOUND:74030550

subject_name: Sugammadex

object_name: brain cancer


subject: CHEBI:50730

subject_name: Montelukast

object_name: Alzheimer disease type 1


subject: CHEBI:50730

object_name: Alzheimer disease


subject: UMLS:C4732998

object_name: cancer


subject: UMLS:C4732998

object_name: neoplasm


subject: CHEMBL.COMPOUND:CHEMBL2109610

object_name: human T-lymphotropic virus 1 infectious disease


subject: CHEBI:184662

object_name: Metastatic malignant neoplasm to pancreas


subject: CHEMBL.COMPOUND:CHEMBL256907

subject_name: maraviroc


subject: CHEBI:63608

subject_name: Maraviroc


subject: UNII:ZK89EG3A18

subject_name: MASITINIB MESYLATE


subject: UMLS:C2698019

subject_name: masitinib mesylate


subject: CHEBI:7514

subject_name: Neostigmine

object_name: intestinal disorder


subject: CHEBI:7496

subject_name: Nelfinavir

object_name: adult liposarcoma


subject: CHEBI:7496

object_name: Recurrent Adult Soft Tissue Sarcoma


subject: CHEBI:7496

object_name: stage III adult soft tissue sarcoma


subject: CHEBI:7496

object_name: Stage IV adult soft tissue sarcoma


subject: CHEBI:2569

subject_name: Alfentanil

object_name: post operative nausea and vomiting


subject: CHEBI:4445

subject_name: Desflurane


subject: CHEBI:4683

subject_name: Anzemet (TN)


subject: UNII:U3C8E5BWKR

subject_name: DOLASETRON MESYLATE


subject: PUBCHEM.COMPOUND:60654

subject_name: Dolasetron


subject: UMLS:C0694955

subject_name: INJECTION, DOLASETRON MESYLATE, 10 MG ADMINISTERED


subject: CHEBI:6015

subject_name: Isoflurane


subject: CHEBI:6709

subject_name: Meclizine


subject: CHEBI:6754

subject_name: Meperidine


subject: CHEBI:7865

subject_name: Oxymorphone


subject: CHEMBL.COMPOUND:CHEMBL1187846

subject_name: SCOPOLAMINE


subject: KEGG.COMPOUND:C01851

subject_name: Scopolamine


subject: CHEBI:91541


subject: CHEBI:9316

subject_name: Sufentanil


subject: CHEBI:94647

subject_name: Tropisetron


subject: CHEBI:32269


subject: CHEBI:29708

subject_name: Zinc gluconate

object_name: Coronavinae infectious disease


subject: CHEBI:33198

subject_name: Gluconic Acid


subject: PUBCHEM.COMPOUND:23664049

subject_name: SODIUM GLUCONATE


subject: CHEBI:60802

subject_name: ropivacaine

object_name: Injection site anesthesia


subject: CHEBI:60802

object_name: Knee Injuries


subject: UMLS:C1328727

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C1328727

object_name: acute myeloid leukemia


subject: UMLS:C1328727

object_name: Myelodysplasia


subject: UMLS:C1328727

object_name: Adult Myelodysplastic Syndrome


subject: UMLS:C1328727

object_name: childhood myelodysplastic syndrome


subject: UMLS:C1328727

object_name: Myelodysplastic Syndrome, CTCAE


subject: UMLS:C1328727

object_name: myeloproliferative neoplasm


subject: UMLS:C1328727

object_name: Malignant myeloproliferative neoplasm


subject: UMLS:C1328727

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: UMLS:C4726002

object_name: oropharyngeal carcinoma


subject: UMLS:C4726002

object_name: oropharynx cancer


subject: UMLS:C4726002

object_name: Malignant neoplasm of lip, oral cavity and pharynx


subject: UMLS:C4726002

object_name: Malignant neoplasms of ill-defined, secondary and unspecified sites


subject: GTOPDB:9244

subject_name: utomilumab


subject: GTOPDB:9244


subject: GTOPDB:9244


subject: GTOPDB:9244


subject: CHEMBL.COMPOUND:CHEMBL3707324

subject_name: UTOMILUMAB


subject: CHEMBL.COMPOUND:CHEMBL3707324


subject: CHEMBL.COMPOUND:CHEMBL3707324


subject: CHEMBL.COMPOUND:CHEMBL3707324


subject: UMLS:C3529795


subject: UMLS:C3529795


subject: UMLS:C3529795


subject: UMLS:C3529795


subject: UMLS:C5416840

subject_name: Platelet Lysate

object_name: Rest limb pain


subject: CHEBI:9241

subject_name: Spironolactone

object_name: Melasma


subject: UNII:T4RS462G19

subject_name: Almonertinib

object_name: Non-small cell lung cancer stage IIIA


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: retina lymphoma


subject: CHEBI:41879

object_name: diffuse large B-cell lymphoma of the central nervous system


subject: CHEBI:41879

object_name: High Grade B-Cell Lymphoma, Not Otherwise Specified


subject: CHEBI:72690

subject_name: Pomalidomide


subject: CHEBI:72690

object_name: intraocular lymphoma


subject: CHEBI:72690


subject: CHEBI:72690

object_name: Recurrent Adult Diffuse Large Cell Lymphoma


subject: CHEBI:72690


subject: PUBCHEM.COMPOUND:53477758

subject_name: Oxytocin

object_name: adult acute respiratory distress syndrome


subject: PUBCHEM.COMPOUND:53477758

object_name: newborn respiratory distress syndrome


subject: UMLS:C0592155

subject_name: Syntocinon


subject: UMLS:C0592155


subject: CHEMBL.COMPOUND:CHEMBL5315009

subject_name: TARPERPRUMIG

object_name: anti-neutrophil cytoplasmic antibody-associated vasculitis


subject: UMLS:C5960148

subject_name: Tarperprumig


subject: CHEBI:39162

subject_name: (R)-nicotine

object_name: nicotine dependence


subject: PUBCHEM.COMPOUND:5316

subject_name: Sulbactam

object_name: respiratory tract infectious disorder


subject: PUBCHEM.COMPOUND:5316

object_name: urinary tract infection


subject: PUBCHEM.COMPOUND:5316

object_name: Recurrent urinary tract infections


subject: UMLS:C5848866

subject_name: Immunotherapy [APC]

object_name: malignant pleural mesothelioma


subject: UNII:FYS6T7F842

subject_name: Adalimumab

object_name: diabetes mellitus


subject: UNII:FYS6T7F842

object_name: type 1 diabetes mellitus 1


subject: UNII:FYS6T7F842

object_name: Autoimmunity


subject: UNII:FYS6T7F842

object_name: hypoglycemia


subject: UNII:FYS6T7F842

object_name: Blood glucose below reference range (finding)


subject: UNII:FYS6T7F842

object_name: Hypoglycemia, CTCAE


subject: UMLS:C0003442

subject_name: lymphocyte immune globulin, anti-thymocyte globulin


subject: CHEBI:64073


subject: UNII:9P1872D4OL

subject_name: Exenatide


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PUBCHEM.COMPOUND:71271414

object_name: bipolar I disorder


subject: UNII:7M430JI73B


subject: UMLS:C0784217

subject_name: salt substitutes

object_name: cardiovascular disorder


subject: UMLS:C0784217

object_name: Blood Pressure Finding


subject: UMLS:C0784217

object_name: Systemic arterial pressure


subject: UMLS:C0784217

object_name: Adverse Event Associated with Death


subject: UMLS:C0784217

object_name: Death (finding)


subject: UMLS:C0784217

object_name: Death


subject: UNII:HJT620308C

subject_name: SALT SUBSTITUTE


subject: UNII:HJT620308C


subject: UNII:HJT620308C


subject: UNII:HJT620308C


subject: UNII:HJT620308C


subject: UNII:HJT620308C


subject: CHEBI:64816

object_name: Advanced Sarcoma


subject: CHEBI:91872


subject: GTOPDB:10492

subject_name: envafolimab

object_name: Metastatic sarcoma


subject: GTOPDB:10492


subject: GTOPDB:10492

object_name: Childhood Soft Tissue Sarcoma


subject: GTOPDB:10492

object_name: Adult Soft Tissue Sarcoma


subject: GTOPDB:10492

object_name: sarcoma


subject: GTOPDB:10492

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: GTOPDB:10492

object_name: soft tissue sarcoma


subject: UNII:ES1M06M6QH


subject: UNII:ES1M06M6QH


subject: UNII:ES1M06M6QH


subject: UNII:ES1M06M6QH


subject: UNII:ES1M06M6QH


subject: UNII:ES1M06M6QH


subject: UNII:ES1M06M6QH


subject: UMLS:C4329339


subject: UMLS:C4329339


subject: UMLS:C4329339


subject: UMLS:C4329339


subject: UMLS:C4329339


subject: UMLS:C4329339


subject: UMLS:C4329339


subject: UMLS:C5447487

subject_name: Anti-CTLA-4 Monoclonal Antibody YH001


subject: UMLS:C5447487


subject: UMLS:C5447487


subject: UMLS:C5447487


subject: UMLS:C5447487


subject: UMLS:C5447487


subject: UMLS:C5447487


subject: UMLS:C5783547

subject_name: Nelmastobart

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:60802

subject_name: ropivacaine

object_name: Disorder of shoulder


subject: UNII:V8ZG4Y1B51

subject_name: TALABOSTAT MESYLATE


subject: UNII:V8ZG4Y1B51

object_name: Recurrent Malignant Solid Neoplasm


subject: UMLS:C1311786

subject_name: PT-100 dipeptide


subject: UMLS:C1311786


subject: UNII:MRL3739G66

subject_name: Dotatate

object_name: carcinoid heart disease


subject: UNII:MRL3739G66

object_name: carcinoid syndrome


subject: UMLS:C1831883

object_name: liver carcinoma


subject: UMLS:C0445115

subject_name: Normal saline

object_name: carpal tunnel syndrome 1


subject: UMLS:C0445115

object_name: carpal tunnel syndrome


subject: PUBCHEM.COMPOUND:71226663

subject_name: Acalabrutinib

object_name: Hepatic impairment


subject: CHEBI:144094

subject_name: bicalutamide

object_name: Triple-Negative Breast Cancer Finding


subject: CHEBI:230905

subject_name: Ribociclib


subject: UMLS:C2974815

subject_name: SAM 315

object_name: Alzheimer disease type 1


subject: UMLS:C2974815

object_name: Alzheimer disease


subject: CHEMBL.COMPOUND:CHEMBL2107910

subject_name: OLIVE OIL

object_name: Postoperative ileus


subject: UMLS:C1550678

subject_name: Water Specimen


subject: CHEBI:15377

subject_name: Water


subject: CHEBI:9168

subject_name: Sirolimus

object_name: polyposis


subject: CHEBI:9168

object_name: Bannayan-Riley-Ruvalcaba syndrome


subject: UMLS:C3714803

subject_name: Vitamin E Drug Class

object_name: respiratory system disorder


subject: CHEMBL.COMPOUND:CHEMBL3989727

subject_name: VITAMIN E


subject: CHEBI:18145

subject_name: Vitamin E


subject: GTOPDB:12964

subject_name: tozorakimab

object_name: asthma


subject: CHEMBL.COMPOUND:CHEMBL4650490

subject_name: TOZORAKIMAB


subject: UMLS:C5557541

subject_name: Immunoglobulin G1-lambda2, anti-[Homo sapiens IL33 (interleukin 33, DVS27, NF-HEV, IL1F11)], monoclonal antibody; gamma1 heavy chain (1-456) [VH (Homo sapiens IGHV3-23*01 (93.9%) -(IGHD) -IGHJ4*01 (85.7%) L123>M (121)) CDR-IMGT [8.8.19] (26-33.51-58.97-1


subject: CHEBI:77733

subject_name: Verapamil

object_name: epilepsy


subject: CHEBI:77733

object_name: Seizure Related to COVID-19


subject: CHEBI:77733

object_name: visual epilepsy


subject: UNII:3G67X40A29

object_name: breast neoplasm


subject: CHEBI:5778

subject_name: Hydrochlorothiazide

object_name: skin sensitivity to sun


subject: CHEBI:5778

object_name: photoparoxysmal response 1


subject: CHEBI:5778

object_name: Photosensitivity, CTCAE


subject: MESH:C045153

subject_name: Maxepa

object_name: type 2 diabetes mellitus


subject: PR:000014338

subject_name: RNA 3'-terminal phosphate cyclase

object_name: ulcerative colitis


subject: PR:000014338

object_name: inflammatory bowel disease 1


subject: UNII:I8309403R0

subject_name: Peginterferon beta-1a

object_name: Multiple sclerosis relapse


subject: CHEBI:85154

subject_name: Akynzeo

object_name: neoplasm


subject: RXCUI:1552339

subject_name: netupitant / palonosetron Oral Product


subject: CHEBI:187893

subject_name: Baclofen


subject: CHEBI:187893

object_name: unspecified adult solid tumor, protocol specific


subject: CHEBI:187893

object_name: myeloproliferative neoplasm


subject: CHEBI:187893

object_name: lymphoproliferative syndrome


subject: CHEBI:187893

object_name: Myelodysplasia


subject: CHEBI:187893

object_name: neurotoxicity


subject: CHEBI:187893

object_name: leukemia


subject: CHEBI:187893

object_name: childhood leukemia


subject: CHEBI:187893

object_name: adult lymphoma


subject: CHEBI:187893

object_name: lymphoma


subject: CHEBI:187893

object_name: pediatric lymphoma


subject: CHEBI:2666

subject_name: Amitriptyline


subject: CHEBI:2666


subject: CHEBI:2666


subject: CHEBI:2666


subject: CHEBI:2666


subject: CHEBI:2666


subject: CHEBI:2666


subject: CHEBI:2666


subject: CHEBI:2666


subject: CHEBI:2666


subject: CHEBI:2666


subject: UNII:M487QF2F4V

subject_name: AMIFOSTINE

object_name: peritoneum cancer


subject: UMLS:C1706792

subject_name: Amifostine Trihydrate


subject: CHEBI:2636

subject_name: Amifostine


subject: CHEBI:167574

subject_name: Semaglutide

object_name: maturity-onset diabetes of the young type 1


subject: CHEBI:32360

subject_name: icosanoate

object_name: osteoarthritis


subject: CHEBI:32360

object_name: osteoarthritis susceptibility 1


subject: CHEBI:135145

subject_name: Neridronic Acid

object_name: Cooley's anemia


subject: CHEBI:135145

object_name: beta thalassemia


subject: CHEBI:135145

object_name: Thalassemia Intermedia


subject: CHEBI:135145

object_name: osteoporosis


subject: CHEBI:135145

object_name: Encounter due to family history of osteoporosis


subject: CHEBI:135145

object_name: Osteoporosis, CTCAE 5.0


subject: CHEBI:135145

object_name: Osteoporosis, CTCAE 3.0


subject: CHEBI:31300

subject_name: BOSENTAN

object_name: Port-Wine Stain


subject: CHEBI:51450

subject_name: Bosentan


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: Advanced Biliary Tract Carcinoma


subject: UMLS:C3641122


subject: UNII:QEN1X95CIX

subject_name: Tremelimumab


subject: UNII:QEN1X95CIX

object_name: Advanced Bile Duct Carcinoma


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: CHEMBL.COMPOUND:CHEMBL5095325

subject_name: NOMLABOFUSP

object_name: Friedreich ataxia


subject: CHEMBL.COMPOUND:CHEMBL5095325

object_name: Friedreich ataxia 1


subject: UMLS:C5708918

subject_name: Nomlabofusp


subject: UMLS:C5708918


subject: CHEBI:7476

subject_name: Naproxen

object_name: sciatica


subject: UMLS:C5446615

subject_name: ALK2 Inhibitor INCB000928

object_name: kidney failure


subject: UMLS:C2346820

object_name: HER2 protein overexpression


subject: UMLS:C4287766

object_name: carcinoma of esophagus


subject: UMLS:C4287766

object_name: esophageal cancer


subject: UMLS:C4287766

object_name: Childhood Esophageal Carcinoma


subject: UMLS:C4287766

object_name: neoplasm of esophagus


subject: UMLS:C4287766

object_name: Gastroesophageal junction cancer


subject: UMLS:C0873137

subject_name: Korean ginseng preparation

object_name: Solid Neoplasm


subject: DRUGBANK:DB01404

subject_name: Ginseng


subject: UMLS:C5444072

subject_name: Panax ginseng allergen


subject: CHEBI:26710

subject_name: Sodium chloride

object_name: Zika fever


subject: CHEBI:64045

subject_name: Amisulpride

object_name: Chronic pain


subject: CHEBI:64045

object_name: Widespread Chronic Pain


subject: CHEBI:64045

object_name: fibromyalgia


subject: UMLS:C4720021

subject_name: Bromocriptine Mesylate Capsules


subject: UMLS:C4720021


subject: UMLS:C4720021


subject: MESH:D000077325

subject_name: Ringer's Lactate

object_name: pregnancy related


subject: MESH:D000077325

object_name: Fluid Overload


subject: MESH:D000077325

object_name: Hypervolemia


subject: MESH:D000077325

object_name: Obstetric Labor Complications


subject: CHEBI:8081

subject_name: Phentolamine

object_name: hypoglycemia


subject: CHEBI:8081

object_name: Blood glucose below reference range (finding)


subject: CHEBI:8081

object_name: Hypoglycemia, CTCAE


subject: CHEBI:8081

object_name: Loss of hypoglycemic warning due to diabetes mellitus


subject: CHEBI:8499

subject_name: Propranolol


subject: CHEBI:8499


subject: CHEBI:8499


subject: CHEBI:8499


subject: PUBCHEM.COMPOUND:92043599

subject_name: epoetin alfa

object_name: subarachnoid hemorrhage


subject: UNII:S3VP91C4JO

subject_name: Ropanicant

object_name: endogenous depression


subject: UNII:S3VP91C4JO

object_name: major depressive disorder


subject: DRUGBANK:DB19134


subject: DRUGBANK:DB19134


subject: UMLS:C3493556

object_name: bladder tumor


subject: UMLS:C3493556

object_name: urinary bladder cancer


subject: UMLS:C3493556

object_name: childhood bladder carcinoma


subject: RXCUI:1999667

subject_name: bictegravir 50 MG / emtricitabine 200 MG / tenofovir alafenamide 25 MG Oral Tablet

object_name: Drug usage


subject: RXCUI:1999667

object_name: Drug use history


subject: RXCUI:1999667

object_name: Encounter due to drug use


subject: DRUGBANK:DB05014

object_name: cancer


subject: DRUGBANK:DB05014

object_name: neoplasm


subject: UNII:TWF0ML1CK8

subject_name: Fluzoparib

object_name: endometrial carcinoma


subject: CHEBI:49040

subject_name: Ezetimibe

object_name: Combined hyperlipidaemia


subject: UNII:4L1AM42NVA

object_name: myelofibrosis


subject: UNII:4L1AM42NVA

object_name: essential thrombocythemia


subject: UNII:4L1AM42NVA

object_name: myeloproliferative neoplasm


subject: UMLS:C2983773


subject: UMLS:C2983773


subject: UMLS:C2983773


subject: CHEBI:85662

subject_name: Lixisenatide

object_name: Parkinson disease


subject: CHEBI:38290

subject_name: L-ascorbate

object_name: chronic pain (diagnosis)


subject: CHEBI:38290

object_name: Chronic pain


subject: CHEBI:176783

subject_name: vitamin C


subject: CHEBI:176783


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C3714687


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: UMLS:C2349136


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: CHEBI:22652


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: UMLS:C4522080


subject: UNII:YWY620GU8I


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin

object_name: hormone-resistant prostate carcinoma


subject: PUBCHEM.COMPOUND:43805

object_name: Prostate cancer recurrent


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: CHEBI:95021

subject_name: pemetrexed


subject: CHEBI:95021


subject: CHEBI:95001

subject_name: Dalcetrapib

object_name: inherited lipid metabolism disorder


subject: CHEBI:95001

object_name: Dyslipidemia


subject: CHEBI:230386

subject_name: Pimonidazole

object_name: kidney disorder


subject: CHEBI:230386

object_name: impaired renal function disease


subject: UMLS:C0972208


subject: UMLS:C0972208


subject: UMLS:C3640065

subject_name: Bovine Lactoferrin Supplement

object_name: Oral Complication of Chemotherapy


subject: UMLS:C3640065

object_name: Primary malignant neoplasm


subject: UMLS:C3640065

object_name: cancer


subject: UMLS:C3640065

object_name: childhood malignant neoplasm


subject: UMLS:C3640065

object_name: Malignant obstetric neoplasm


subject: UMLS:C3640065

object_name: Cachexia


subject: UMLS:C3640065

object_name: Anorexia


subject: UMLS:C3640065

object_name: Anorexia, CTCAE


subject: UMLS:C3640065

object_name: Anorexia symptom


subject: MESH:D006495

subject_name: Heparin, Low-Molecular-Weight

object_name: arterial occlusion


subject: UMLS:C3536766

subject_name: Low Molecular Weight Heparin [EPC]


subject: CHEBI:231350

subject_name: Pacritinib

object_name: prostate carcinoma


subject: CHEBI:231350

object_name: prostate cancer


subject: CHEBI:42944

subject_name: Galantamine

object_name: Tic Disorders, Vocal


subject: CHEBI:42944

object_name: Motor Tic Disorders


subject: CHEBI:42944

object_name: Tourette syndrome


subject: CHEBI:49668

subject_name: Gefitinib

object_name: Locally advanced prostate cancer


subject: UNII:5S371K6132

subject_name: Rivoceranib

object_name: Recurrent Glioma


subject: CHEBI:5118

subject_name: Fluoxetine

object_name: dysthymic disorder


subject: CHEBI:79699

subject_name: Temsirolimus

object_name: acute myeloid leukemia with minimal differentiation


subject: CHEBI:79699

object_name: acute myeloid leukemia


subject: CHEBI:6402

subject_name: Leflunomide

object_name: nephritis


subject: CHEBI:6402

object_name: EXCESS LMW-DNA


subject: CHEBI:6402

object_name: lupus vulgaris


subject: CHEBI:6402

object_name: lupus erythematosus


subject: CHEBI:6402

object_name: discoid lupus erythematosus


subject: CHEBI:23503

subject_name: DL-Cycloserine

object_name: endogenous depression


subject: CHEBI:23503

object_name: major depressive disorder


subject: PUBCHEM.COMPOUND:135659064

subject_name: Folfox

object_name: Advanced Pancreatic Carcinoma


subject: CHEBI:65265

subject_name: antacid

object_name: HIV infection


subject: UMLS:C0003138

subject_name: Antacids


subject: UMLS:C0003216

subject_name: Anti-Ulcer Agent


subject: PUBCHEM.COMPOUND:49865963

subject_name: TRABECTEDIN

object_name: malignant mesothelioma


subject: PUBCHEM.COMPOUND:3199

subject_name: ecteinascidin 743


subject: CHEBI:16563

subject_name: Tetrahydropalmatine

object_name: schizophrenia


subject: UNII:1L1V1K2M4V

object_name: Insomnia, CTCAE 3.0


subject: UNII:1L1V1K2M4V

object_name: Insomnia, CTCAE 5.0


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin

object_name: germ cell tumor


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED

object_name: Recurrent Childhood Central Nervous System Neoplasm


subject: CHEBI:72564

subject_name: Temozolomide


subject: PUBCHEM.COMPOUND:73151030

subject_name: Empagliflozin

object_name: congenital heart disease


subject: MESH:C000615411

object_name: prostate carcinoma


subject: MESH:C000615411

object_name: prostate cancer


subject: CHEBI:29287

subject_name: Gold


subject: CHEBI:29287


subject: UNII:NTM296JU95


subject: UNII:NTM296JU95


subject: UMLS:C2933414

object_name: bone chondrosarcoma


subject: UMLS:C2933414

object_name: chondrosarcoma


subject: CHEBI:17061

subject_name: D-Glutamine

object_name: type 1 diabetes mellitus


subject: CHEBI:28300

subject_name: glutamine


subject: CHEBI:18050

subject_name: L-Glutamine


subject: DRUGBANK:DB18192

object_name: Rest limb pain


subject: DRUGBANK:DB18192

object_name: Atherosclerosis obliterans


subject: DRUGBANK:DB18192

object_name: Buerger Disease


subject: GTOPDB:5026

subject_name: NGF

object_name: dry eye syndrome


subject: GTOPDB:5026

object_name: Dry Eye, CTCAE


subject: GTOPDB:5026

object_name: Dryness of eye


subject: DRUGBANK:DB16536

subject_name: Birch bark extract

object_name: inherited epidermolysis bullosa


subject: UMLS:C5669860


subject: CHEBI:75998

subject_name: Trametinib


subject: CHEBI:75998

object_name: Locally Advanced Epithelioid Hemangioendothelioma


subject: PUBCHEM.COMPOUND:3062

subject_name: Cogoxin

object_name: Chronic obstructive pulmonary disease exacerbation


subject: PUBCHEM.COMPOUND:3062

object_name: Chronic obstructive pulmonary disease of horses


subject: PUBCHEM.COMPOUND:3062

object_name: COPD, severe early onset


subject: PUBCHEM.COMPOUND:3062

object_name: chronic obstructive pulmonary disease


subject: CHEBI:145795


subject: CHEBI:145795


subject: CHEBI:145795


subject: CHEBI:145795


subject: CHEBI:4551

subject_name: Digoxin


subject: CHEBI:4551


subject: CHEBI:4551


subject: CHEBI:4551


subject: CHEBI:6931

subject_name: Midazolam


subject: CHEBI:6931


subject: CHEBI:6931


subject: CHEBI:6931


subject: CHEBI:77733

subject_name: Verapamil


subject: CHEBI:77733


subject: CHEBI:77733


subject: CHEBI:77733


subject: PUBCHEM.COMPOUND:46783403

subject_name: Rifaximin

object_name: HER2 positive breast carcinoma


subject: PUBCHEM.COMPOUND:46783403

object_name: Anatomic Stage III Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:46783403

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:46783403

object_name: Prognostic Stage III Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:46783403

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:46783403

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:46783403

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:46783403

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:46783403

object_name: Anatomic Stage I Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:46783403

object_name: Anatomic Stage IIB Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:46783403

object_name: Anatomic Stage IIA Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:46783403

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:46783403

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:46783403

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:46783403

object_name: Prognostic Stage I Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:46783403

object_name: Prognostic Stage IIA Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:46783403

object_name: Prognostic Stage IIB Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:46783403

object_name: Anatomic Stage IA Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:46783403

object_name: Anatomic Stage IB Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:46783403

object_name: Prognostic Stage IB Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:46783403

object_name: Prognostic Stage IA Breast Cancer AJCC v8


subject: CHEBI:3441

subject_name: Carvedilol

object_name: Single Ventricle Defect


subject: CHEBI:3441

object_name: Single ventricle


subject: UMLS:C3540778

subject_name: Glucocorticoid inhalants for obstructive airway disease

object_name: anti-neutrophil cytoplasmic antibody-associated vasculitis


subject: CHEBI:24261

subject_name: glucocorticoid


subject: UMLS:C3540777

subject_name: Glucocorticoids, Systemic


subject: CHEBI:6904

subject_name: Metoprolol

object_name: beta thalassemia


subject: UNII:V038D626IF

subject_name: Ashwagandha

object_name: pediatric osteosarcoma


subject: UNII:V038D626IF

object_name: Osteosarcoma


subject: CHEBI:6367

subject_name: Lamotrigine

object_name: cocaine dependence


subject: CHEBI:9130

subject_name: Sevoflurane

object_name: General anesthetic drug adverse reaction


subject: CHEBI:82315

object_name: tracheal stenosis


subject: CHEBI:82315

object_name: Tracheal Stenosis, CTCAE


subject: CHEBI:28435


subject: CHEBI:28435


subject: CHEBI:943

subject_name: dichlobanil


subject: CHEBI:943


subject: DRUGBANK:DB14046

subject_name: Dichlorobenzene


subject: DRUGBANK:DB14046


subject: UMLS:C0003442

subject_name: lymphocyte immune globulin, anti-thymocyte globulin

object_name: vasculitis


subject: UMLS:C0003442

object_name: Vasculitis, CTCAE


subject: UMLS:C1446777

subject_name: Rabbit antigen


subject: UMLS:C1446777


subject: UMLS:C2093603

subject_name: Rabbit


subject: UMLS:C2093603


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: GTOPDB:4934

subject_name: G-CSF


subject: GTOPDB:4934


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: UNII:PVI5M0M1GW


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: CHEBI:31824

subject_name: Mesna


subject: CHEBI:31824


subject: CHEBI:17905

subject_name: Coenzyme M


subject: CHEBI:17905


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: CHEBI:61057


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:61049


subject: UniProtKB:Q64163

subject_name: TFDP2_MOUSE Transcription factor Dp-2 (sprot)

object_name: Recurrent Childhood Glioblastoma


subject: UniProtKB:Q64163

object_name: Recurrent Glioblastoma


subject: PR:000016270

subject_name: transcription factor Dp-2


subject: PR:000016270


subject: CHEBI:3757

subject_name: Clonidine

object_name: orthostatic hypotension


subject: CHEBI:3757

object_name: autonomic nervous system disorder


subject: CHEBI:3757

object_name: Irritable heart


subject: CHEBI:3757

object_name: neurocirculatory asthenia


subject: CHEBI:3757

object_name: orthostatic hypotension 1


subject: CHEBI:10093

subject_name: Yohimbine


subject: CHEBI:10093


subject: CHEBI:10093


subject: CHEBI:107736

subject_name: Metoclopramide


subject: CHEBI:107736


subject: CHEBI:107736


subject: CHEBI:107736


subject: CHEBI:107736


subject: CHEBI:180994


subject: CHEBI:180994


subject: CHEBI:180994


subject: CHEBI:180994


subject: CHEBI:180994


subject: CHEBI:61058

subject_name: Methyldopa


subject: CHEBI:61058


subject: CHEBI:61058


subject: CHEBI:61058


subject: CHEBI:61058


subject: CHEBI:8093

subject_name: Phenylephrine


subject: CHEBI:8093


subject: CHEBI:64317

subject_name: Isoprenaline


subject: CHEBI:64317


subject: UNII:169D1260KM

subject_name: NITROPRUSSIDE


subject: UNII:169D1260KM


subject: UNII:169D1260KM


subject: UNII:169D1260KM


subject: UNII:169D1260KM


subject: PUBCHEM.COMPOUND:129696905


subject: PUBCHEM.COMPOUND:129696905


subject: PUBCHEM.COMPOUND:129696905


subject: PUBCHEM.COMPOUND:129696905


subject: PUBCHEM.COMPOUND:129696905


subject: CHEBI:8499

subject_name: Propranolol


subject: CHEBI:8499


subject: CHEBI:8499


subject: CHEBI:8499


subject: CHEBI:251408

subject_name: Edrophonium


subject: CHEBI:251408


subject: CHEBI:251408


subject: CHEBI:251408


subject: CHEBI:251408


subject: CHEBI:57858

subject_name: atropinium


subject: CHEBI:57858


subject: CHEBI:57858


subject: CHEBI:57858


subject: CHEBI:57858


subject: CHEBI:92712

subject_name: ENDO-ATROPINE


subject: CHEBI:92712


subject: CHEBI:92712


subject: CHEBI:92712


subject: CHEBI:92712


subject: CHEBI:91541


subject: CHEBI:91541


subject: CHEBI:91541


subject: CHEBI:91541


subject: CHEBI:91541


subject: UMLS:C1161352

subject_name: Atropinum, atropine


subject: UMLS:C1161352


subject: UMLS:C1161352


subject: UMLS:C1161352


subject: UMLS:C1161352


subject: CHEBI:327995

subject_name: tyraminium


subject: CHEBI:327995


subject: CHEBI:327995


subject: CHEBI:327995


subject: CHEBI:327995


subject: CHEBI:15760

subject_name: Tyramine


subject: CHEBI:15760


subject: CHEBI:15760


subject: CHEBI:15760


subject: CHEBI:15760


subject: CHEBI:93274

subject_name: Fluvoxamine

object_name: delirium


subject: CHEBI:93274

object_name: Delirium, CTCAE


subject: CHEBI:93274

object_name: Surgery--Complications


subject: CHEBI:6931

subject_name: Midazolam

object_name: spinal muscular atrophy


subject: CHEBI:6931

object_name: proximal spinal muscular atrophy


subject: UMLS:C1145197

subject_name: INJECTION, IRON SUCROSE, 1 MG ADMINISTERED

object_name: Chronic uremia


subject: UMLS:C1145197

object_name: iron deficiency anemia


subject: UMLS:C1831745

subject_name: Iron Sucrose Liquid Injection


subject: UMLS:C1831745


subject: GTOPDB:12990

subject_name: sintilimab

object_name: cholangiocarcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297829

subject_name: SINTILIMAB


subject: UMLS:C4329335

subject_name: IBI 308


subject: CHEBI:84500

subject_name: varenicline

object_name: unspecified adult solid tumor, protocol specific


subject: CHEBI:23995

subject_name: N-ethyl-N-nitrosourea

object_name: Carcinoma breast stage IV


subject: CHEBI:23995

object_name: Breast cancer recurrent


subject: CHEBI:49018

subject_name: neuraminic acid


subject: CHEBI:49018


subject: PR:000011149

subject_name: E3 ubiquitin-protein ligase NEURL1


subject: PR:000011149


subject: PR:000011145


subject: PR:000011145


subject: PR:000002082

subject_name: receptor tyrosine-protein kinase erbB-2


subject: PR:000002082


subject: UniProtKB:P06494

subject_name: ERBB2_RAT Receptor tyrosine-protein kinase erbB-2 (sprot)


subject: UniProtKB:P06494


subject: UMLS:C0982327

subject_name: PEGINTERFERON

object_name: viral hepatitis


subject: UMLS:C0982327

object_name: Viral Hepatitis, CTCAE


subject: UMLS:C0982327

object_name: Chronic liver disease


subject: CHEBI:94463


subject: CHEBI:94463


subject: CHEBI:63580

subject_name: Ribavirin


subject: CHEBI:63580


subject: CHEBI:24814

object_name: Childhood Breast Carcinoma


subject: CHEBI:24814

object_name: breast carcinoma


subject: CHEBI:24814

object_name: breast cancer


subject: UMLS:C5853744

object_name: paroxysmal nocturnal hemoglobinuria


subject: UMLS:C5853744

object_name: periventricular nodular heterotopia


subject: CHEMBL.COMPOUND:CHEMBL5314528

subject_name: LUXDEGALUTAMIDE

object_name: metastatic prostate carcinoma


subject: UMLS:C5666903

subject_name: Luxdegalutamide


subject: CHEBI:88249

subject_name: Mirdametinib

object_name: histiocytic neoplasm


subject: CHEBI:88249

object_name: histiocytic and dendritic cell neoplasm


subject: PUBCHEM.COMPOUND:135742497

subject_name: MEK inhibitor


subject: PUBCHEM.COMPOUND:135742497


subject: UMLS:C2347168

subject_name: Mitogen-Activated Protein Kinase Kinase Inhibitor


subject: UMLS:C2347168


subject: UMLS:C0728976

subject_name: Control brand of phenylpropanolamine

object_name: Iodine deficiency


subject: UMLS:C0308718

subject_name: CONTROL veterinary product


subject: UMLS:C1550141

subject_name: control substance


subject: CHEBI:43451

subject_name: Hydrogen iodide


subject: CHEBI:16382

subject_name: Iodide


subject: MESH:C000619755

object_name: graft versus host disease


subject: CHEBI:36796

subject_name: duloxetine

object_name: Stage III Colorectal Cancer AJCC v8


subject: CHEBI:36796

object_name: Stage II Colorectal Cancer AJCC v8


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: respiratory system disorder


subject: CHEBI:4466

object_name: Difficult tracheal intubation (finding)


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:7N8K34P2XH


subject: MESH:C478920

object_name: xerophthalmia


subject: MESH:C478920

object_name: dry eye syndrome


subject: UMLS:C1310928

object_name: Chronic small plaque psoriasis


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: Recurrent Endometrial Cancer


subject: PUBCHEM.COMPOUND:70789204

object_name: Refractory Endometrial Carcinoma


subject: PUBCHEM.COMPOUND:70789204

object_name: Recurrent Endometrial Endometrioid Adenocarcinoma


subject: PUBCHEM.COMPOUND:70789204

object_name: Refractory Endometrial Endometrioid Adenocarcinoma


subject: PUBCHEM.COMPOUND:70789204

object_name: Stage III Uterine Corpus Cancer AJCC v8


subject: PUBCHEM.COMPOUND:70789204

object_name: Stage IIIC Uterine Corpus Cancer AJCC v8


subject: PUBCHEM.COMPOUND:70789204

object_name: Stage IIIC1 Uterine Corpus Cancer AJCC v8


subject: PUBCHEM.COMPOUND:70789204

object_name: Stage IIIC2 Uterine Corpus Cancer AJCC v8


subject: PUBCHEM.COMPOUND:70789204

object_name: Stage IIIB Uterine Corpus Cancer AJCC v8


subject: PUBCHEM.COMPOUND:70789204

object_name: Stage IIIA Uterine Corpus Cancer AJCC v8


subject: PUBCHEM.COMPOUND:70789204

object_name: Stage IV Uterine Corpus Cancer AJCC v8


subject: PUBCHEM.COMPOUND:70789204

object_name: Stage IVB Uterine Corpus Cancer AJCC v8


subject: PUBCHEM.COMPOUND:70789204

object_name: Stage IVA Uterine Corpus Cancer AJCC v8


subject: CHEBI:6413

subject_name: Letrozole


subject: CHEBI:6413


subject: CHEBI:6413


subject: CHEBI:6413


subject: CHEBI:6413


subject: CHEBI:6413


subject: CHEBI:6413


subject: CHEBI:6413


subject: CHEBI:6413


subject: CHEBI:6413


subject: CHEBI:6413


subject: CHEBI:6413


subject: CHEBI:230905

subject_name: Ribociclib


subject: CHEBI:230905


subject: CHEBI:230905


subject: CHEBI:230905


subject: CHEBI:230905


subject: CHEBI:230905


subject: CHEBI:230905


subject: CHEBI:230905


subject: CHEBI:230905


subject: CHEBI:230905


subject: CHEBI:230905


subject: CHEBI:230905


subject: CHEBI:230905


subject: UMLS:C0770694

subject_name: trivalent influenza vaccine

object_name: respiratory tract infectious disorder


subject: CHEBI:33704

subject_name: Amino acid

object_name: coronary artery disorder


subject: CHEBI:33704

object_name: coronary atherosclerosis


subject: PUBCHEM.COMPOUND:169449957

subject_name: Amino Acids


subject: PUBCHEM.COMPOUND:169449957


subject: CHEMBL.COMPOUND:CHEMBL1201498

subject_name: AMINO ACIDS


subject: CHEMBL.COMPOUND:CHEMBL1201498


subject: UMLS:C3539946

subject_name: Amino Acids, I.V. solution additive


subject: UMLS:C3539946


subject: UMLS:C0002520


subject: UMLS:C0002520


subject: UMLS:C3539947

subject_name: Antifibrinolytic amino acids


subject: UMLS:C3539947


subject: UMLS:C5544334

object_name: pulmonary hypertension, primary, 1


subject: UMLS:C5544334

object_name: idiopathic pulmonary arterial hypertension


subject: UMLS:C5544334

object_name: pulmonary arterial hypertension


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: ectopic pregnancy


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: UniProtKB:P47802

subject_name: MTX1_MOUSE Metaxin-1 (sprot)


subject: PR:000010755


subject: UNII:16VY3TM7ZO

subject_name: Antineoplaston A10

object_name: Childhood Neuroblastoma


subject: UNII:16VY3TM7ZO

object_name: neuroblastoma


subject: UMLS:C4721487

subject_name: ATENGENAL


subject: UMLS:C4721487


subject: UMLS:C4721495

subject_name: Astugenal


subject: UMLS:C4721495


subject: CHEBI:6129

subject_name: Ketorolac

object_name: Pain of sacroiliac joint


subject: CHEBI:6888

subject_name: Methylprednisolone


subject: CHEBI:38721

subject_name: Methamidophos

object_name: plasma cell myeloma


subject: CHEBI:68579

subject_name: Rivaroxaban

object_name: May-Thurner syndrome


subject: UMLS:C3661275

object_name: Solid Neoplasm


subject: UMLS:C3661275

object_name: Carcinoma breast stage IV


subject: CHEBI:91450

subject_name: Sapanisertib


subject: MESH:C000711370

object_name: esophageal disorder


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina

object_name: coronary microvascular disorder


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: UMLS:C3265062


subject: UMLS:C5447434

subject_name: Tempol-containing MBM-02

object_name: prostate carcinoma


subject: UMLS:C5447434

object_name: prostate cancer


subject: CHEBI:180664

subject_name: Tempol


subject: CHEBI:180664


subject: UMLS:C5204405

subject_name: Botulinum Toxin E EB-001

object_name: Musculoskeletal Pain


subject: PUBCHEM.COMPOUND:3222

object_name: Myocardial fibrosis


subject: PUBCHEM.COMPOUND:3222

object_name: muscular dystrophy


subject: CHEBI:4784

subject_name: Enalapril


subject: CHEBI:4784


subject: CHEBI:6456

subject_name: Lidocaine

object_name: uterine fibroid


subject: CHEBI:6456

object_name: Enlarged uterus


subject: CHEBI:6456

object_name: Adnexal mass


subject: CHEBI:58097


subject: CHEBI:58097


subject: CHEBI:58097


subject: CHEBI:17303

subject_name: Morphine


subject: CHEBI:17303


subject: CHEBI:17303


subject: CHEBI:6950

subject_name: Mirtazapine

object_name: Intracranial glioma


subject: UMLS:C5432265

subject_name: Goflikicept

object_name: Recurrent pericarditis


subject: UMLS:C0939246

subject_name: Advair Diskus

object_name: asthma


subject: CHEBI:25417

subject_name: montanoyl group


subject: UniProtKB:Q6E2N3

subject_name: TRI33_DANRE E3 ubiquitin-protein ligase TRIM33 (sprot)


subject: CHEBI:64019

subject_name: Nebivolol

object_name: coronary vasospasm


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: myocardial ischemia